| Year |
Citation |
Score |
| 2022 |
Meijboom KE, Sutton ER, McCallion E, McFall E, Anthony D, Edwards B, Kubinski S, Tapken I, Bünermann I, Hazell G, Ahlskog N, Claus P, Davies KE, Kothary R, Wood MJA, et al. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice. Skeletal Muscle. 12: 18. PMID 35902978 DOI: 10.1186/s13395-022-00301-z |
0.459 |
|
| 2021 |
Ang G, Brown LA, Tam SKE, Davies KE, Foster RG, Harrison PJ, Sprengel R, Vyazovskiy VV, Oliver PL, Bannerman DM, Peirson SN. Deletion of AMPA receptor GluA1 subunit gene (Gria1) causes circadian rhythm disruption and aberrant responses to environmental cues. Translational Psychiatry. 11: 588. PMID 34782594 DOI: 10.1038/s41398-021-01690-3 |
0.722 |
|
| 2021 |
Vuorinen A, Wilkinson IVL, Chatzopoulou M, Edwards B, Squire SE, Fairclough RJ, Bazan NA, Milner JA, Conole D, Donald JR, Shah N, Willis NJ, Martínez RF, Wilson FX, Wynne GM, ... ... Davies KE, et al. Discovery and mechanism of action studies of 4,6-diphenylpyrimidine-2-carbohydrazides as utrophin modulators for the treatment of Duchenne muscular dystrophy. European Journal of Medicinal Chemistry. 220: 113431. PMID 33915371 DOI: 10.1016/j.ejmech.2021.113431 |
0.591 |
|
| 2020 |
Lovering RM, Iyer SR, Edwards B, Davies KE. Alterations of neuromuscular junctions in Duchenne muscular dystrophy. Neuroscience Letters. 135304. PMID 32818587 DOI: 10.1016/J.Neulet.2020.135304 |
0.509 |
|
| 2020 |
Babbs A, Berg A, Chatzopoulou M, Davies KE, Davies SG, Edwards B, Elsey DJ, Emer E, Figuccia ALA, Fletcher AM, Guiraud S, Harriman S, Moir L, Robinson N, Rowley JA, et al. Synthesis of SMT022357 enantiomers and evaluation in a Duchenne muscular dystrophy mouse model. Tetrahedron. 76: 130819. PMID 32713969 DOI: 10.1016/J.Tet.2019.130819 |
0.474 |
|
| 2020 |
Babbs A, Chatzopoulou M, Edwards B, Squire SE, Wilkinson IVL, Wynne GM, Russell AJ, Davies KE. From diagnosis to therapy in Duchenne muscular dystrophy. Biochemical Society Transactions. PMID 32597486 DOI: 10.1042/Bst20190282 |
0.356 |
|
| 2020 |
Babbs A, Berg A, Chatzopoulou M, Davies KE, Davies SG, Edwards B, Elsey D, Emer E, Guiraud S, Harriman S, Lecci C, Moir L, Peters D, Robinson N, Rowley J, et al. 2-Arylbenzo[d]oxazole phosphinate esters as second-generation modulators of utrophin for the treatment of Duchenne Muscular Dystrophy. Journal of Medicinal Chemistry. PMID 32551645 DOI: 10.1021/Acs.Jmedchem.0C00807 |
0.489 |
|
| 2019 |
Wilkinson IVL, Perkins KJ, Dugdale H, Moir L, Vuorinen A, Chatzopoulou M, Squire SE, Monecke S, Lomow A, Geese M, Charles PD, Burch P, Tinsley JM, Wynne GM, Davies SG, ... ... Davies KE, et al. Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid. Angewandte Chemie (International Ed. in English). PMID 31755636 DOI: 10.1002/Anie.201912392 |
0.342 |
|
| 2019 |
Williamson MG, Finelli MJ, Sleigh JN, Reddington A, Gordon D, Talbot K, Davies KE, Oliver PL. Neuronal over-expression of Oxr1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo. Human Molecular Genetics. PMID 31642482 DOI: 10.1093/Hmg/Ddz190 |
0.805 |
|
| 2019 |
Davies KE, Chamberlain JS. Surrogate gene therapy for muscular dystrophy. Nature Medicine. PMID 31591598 DOI: 10.1038/s41591-019-0604-2 |
0.324 |
|
| 2019 |
Pomatto LCD, Sun PY, Yu K, Gullapalli S, Bwiza CP, Sisliyan C, Wong S, Zhang H, Forman HJ, Oliver PL, Davies KE, Davies KJA. Limitations to adaptive homeostasis in an hyperoxia-induced model of accelerated ageing. Redox Biology. 24: 101194. PMID 31022673 DOI: 10.1016/J.Redox.2019.101194 |
0.728 |
|
| 2019 |
Guiraud S, Edwards B, Babbs A, Squire SE, Berg A, Moir L, Wood MJ, Davies KE. The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. Human Molecular Genetics. PMID 30990876 DOI: 10.1093/Hmg/Ddz049 |
0.528 |
|
| 2019 |
Guiraud S, Davies KE. Regenerative biomarkers for Duchenne muscular dystrophy. Neural Regeneration Research. 14: 1317-1320. PMID 30964048 DOI: 10.4103/1673-5374.253534 |
0.323 |
|
| 2018 |
Kennedy TL, Guiraud S, Edwards B, Squire S, Moir L, Babbs A, Odom G, Golebiowski D, Schneider J, Chamberlain JS, Davies KE. Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/ Mice. Molecular Therapy. Methods & Clinical Development. 11: 92-105. PMID 30417024 DOI: 10.1016/J.Omtm.2018.10.005 |
0.349 |
|
| 2018 |
Guiraud S, Edwards B, Squire SE, Moir L, Berg A, Babbs A, Ramadan N, Wood MJ, Davies KE. Embryonic myosin is a regeneration marker to monitor utrophin based therapies for DMD. Human Molecular Genetics. PMID 30304405 DOI: 10.1093/Hmg/Ddy353 |
0.529 |
|
| 2018 |
Ang G, McKillop LE, Purple R, Blanco-Duque C, Peirson SN, Foster RG, Harrison PJ, Sprengel R, Davies KE, Oliver PL, Bannerman DM, Vyazovskiy VV. Absent sleep EEG spindle activity in GluA1 (Gria1) knockout mice: relevance to neuropsychiatric disorders. Translational Psychiatry. 8: 154. PMID 30108203 DOI: 10.1038/S41398-018-0199-2 |
0.721 |
|
| 2018 |
Perkins KJ, Davies KE. Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy. Febs Letters. PMID 29772070 DOI: 10.1002/1873-3468.13099 |
0.347 |
|
| 2017 |
Kennedy TL, Moir L, Hemming S, Edwards B, Squire S, Davies K, Guiraud S. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle. Skeletal Muscle. 7: 22. PMID 29065908 DOI: 10.1186/S13395-017-0139-5 |
0.306 |
|
| 2017 |
Guiraud S, Davies KE. Pharmacological advances for treatment in Duchenne muscular dystrophy. Current Opinion in Pharmacology. 34: 36-48. PMID 28486179 DOI: 10.1016/j.coph.2017.04.002 |
0.333 |
|
| 2017 |
Guiraud S, Edwards B, Squire SE, Babbs A, Shah N, Berg A, Chen H, Davies KE. Identification of serum protein biomarkers for utrophin based DMD therapy. Scientific Reports. 7: 43697. PMID 28252048 DOI: 10.1016/J.Nmd.2017.06.269 |
0.533 |
|
| 2016 |
Wu Y, Davies KE, Oliver PL. The antioxidant protein Oxr1 influences aspects of mitochondrial morphology. Free Radical Biology & Medicine. PMID 27036366 DOI: 10.1016/J.Freeradbiomed.2016.03.029 |
0.744 |
|
| 2015 |
Finelli MJ, Sanchez-Pulido L, Liu KX, Davies KE, Oliver PL. The evolutionarily conserved Tre2/Bub2/Cdc16 (TBC), Lysin motif (LysM), Domain catalytic (TLDc) domain is neuroprotective against oxidative stress. The Journal of Biological Chemistry. PMID 26668325 DOI: 10.1074/Jbc.M115.685222 |
0.784 |
|
| 2015 |
Pembroke WG, Babbs A, Davies K, Ponting CP, Oliver PL. Temporal transcriptomics suggest that twin-peaking genes reset the clock. Elife. 4. PMID 26523393 DOI: 10.7554/Elife.10518 |
0.743 |
|
| 2015 |
Richardson K, Livieratos A, Dumbill R, Hughes S, Ang G, Smith DA, Morris L, Brown LA, Peirson SN, Platt FM, Davies KE, Oliver PL. Circadian profiling in two mouse models of lysosomal storage disorders; Niemann Pick type-C and Sandhoff disease. Behavioural Brain Research. 297: 213-223. PMID 26467605 DOI: 10.1016/J.Bbr.2015.10.021 |
0.758 |
|
| 2015 |
Guiraud S, Chen H, Burns DT, Davies KE. Advances in genetic therapeutic strategies for Duchenne muscular dystrophy. Experimental Physiology. PMID 26140505 DOI: 10.1113/EP085308 |
0.39 |
|
| 2015 |
Guiraud S, Aartsma-Rus A, Vieira NM, Davies KE, van Ommen GJ, Kunkel LM. The Pathogenesis and Therapy of Muscular Dystrophies. Annual Review of Genomics and Human Genetics. PMID 26048046 DOI: 10.1146/annurev-genom-090314-025003 |
0.403 |
|
| 2015 |
Guiraud S, Squire SE, Edwards B, Chen H, Burns DT, Shah N, Babbs A, Davies SG, Wynne GM, Russell AJ, Elsey D, Wilson FX, Tinsley JM, Davies KE. Second-generation compound for the modulation of utrophin in the therapy of DMD. Human Molecular Genetics. 24: 4212-24. PMID 25935002 DOI: 10.1093/Hmg/Ddv154 |
0.537 |
|
| 2015 |
Dulneva A, Lee S, Oliver PL, Di Gleria K, Kessler BM, Davies KE, Becker EB. The mutant Moonwalker TRPC3 channel links calcium signaling to lipid metabolism in the developing cerebellum. Human Molecular Genetics. 24: 4114-25. PMID 25908616 DOI: 10.1093/Hmg/Ddv150 |
0.775 |
|
| 2015 |
Finelli MJ, Liu KX, Wu Y, Oliver PL, Davies KE. Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations. Human Molecular Genetics. 24: 3529-44. PMID 25792726 DOI: 10.1093/Hmg/Ddv104 |
0.802 |
|
| 2015 |
Liu KX, Edwards B, Lee S, Finelli MJ, Davies B, Davies KE, Oliver PL. Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. Brain : a Journal of Neurology. 138: 1167-81. PMID 25753484 DOI: 10.1093/Brain/Awv039 |
0.794 |
|
| 2015 |
Goyenvalle A, Griffith G, Babbs A, El Andaloussi S, Ezzat K, Avril A, Dugovic B, Chaussenot R, Ferry A, Voit T, Amthor H, Bühr C, Schürch S, Wood MJ, Davies KE, et al. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers. Nature Medicine. 21: 270-5. PMID 25642938 DOI: 10.1038/Nm.3765 |
0.37 |
|
| 2015 |
Pembroke WG, Babbs A, Davies KE, Ponting CP, Oliver PL. Author response: Temporal transcriptomics suggest that twin-peaking genes reset the clock Elife. DOI: 10.7554/Elife.10518.033 |
0.728 |
|
| 2015 |
Araujo N, Vuorinen A, Fairclough R, Guiraud S, Donald J, Cairnduff C, Hewings D, Martinez F, Csatayova K, Willis N, Squire S, Babbs A, Edwards B, Shah N, Tinsley J, ... ... Davies K, et al. Discovery of small molecule utrophin modulators for the therapy of Duchenne muscular dystrophy (DMD) Neuromuscular Disorders. 25: S260. DOI: 10.1016/J.Nmd.2015.06.272 |
0.579 |
|
| 2015 |
Tinsley J, Janghra N, Morgan J, Sewry C, Muntoni F, Elsey D, Wilson F, Davies K. Biomarker development to support the clinical development of utrophin modulators for Duchenne muscular dystrophy therapy Neuromuscular Disorders. 25: 826. DOI: 10.1016/J.Nmd.2015.06.241 |
0.31 |
|
| 2014 |
Moore JM, Oliver PL, Finelli MJ, Lee S, Lickiss T, Molnár Z, Davies KE. Laf4/Aff3, a gene involved in intellectual disability, is required for cellular migration in the mouse cerebral cortex. Plos One. 9: e105933. PMID 25162227 DOI: 10.1371/Journal.Pone.0105933 |
0.801 |
|
| 2014 |
Paton L, Bitoun E, Kenyon J, Priestman DA, Oliver PL, Edwards B, Platt FM, Davies KE. A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology. The Journal of Biological Chemistry. 289: 26709-21. PMID 25107912 DOI: 10.1074/Jbc.M114.586156 |
0.81 |
|
| 2014 |
Turner BJ, Alfazema N, Sheean RK, Sleigh JN, Davies KE, Horne MK, Talbot K. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice. Neurobiology of Aging. 35: 906-15. PMID 24210254 DOI: 10.1016/J.Neurobiolaging.2013.09.030 |
0.797 |
|
| 2014 |
Taylor TN, Potgieter D, Anwar S, Senior SL, Janezic S, Threlfell S, Ryan B, Parkkinen L, Deltheil T, Cioroch M, Livieratos A, Oliver PL, Jennings KA, Davies KE, Ansorge O, et al. Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse. Neurobiology of Disease. 62: 193-207. PMID 24121116 DOI: 10.1016/J.Nbd.2013.10.005 |
0.745 |
|
| 2014 |
Sleigh JN, Barreiro-Iglesias A, Oliver PL, Biba A, Becker T, Davies KE, Becker CG, Talbot K. Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy. Human Molecular Genetics. 23: 855-69. PMID 24067532 DOI: 10.1093/Hmg/Ddt477 |
0.796 |
|
| 2014 |
Van Rossen E, Liu Z, Blijweert D, Eysackers N, Mannaerts I, Schroyen B, El Taghdouini A, Edwards B, Davies KE, Sokal E, Najimi M, Reynaert H, van Grunsven LA. Syncoilin is an intermediate filament protein in activated hepatic stellate cells. Histochemistry and Cell Biology. 141: 85-99. PMID 24043511 DOI: 10.1007/s00418-013-1142-5 |
0.513 |
|
| 2014 |
Fairclough R, Squire S, Araujo N, Vuorinen A, Davies S, Wynne G, Russell A, Davies K. P13 New orally available compounds which modulate utrophin expression for the therapy of Duchenne muscular dystrophy (DMD) Neuromuscular Disorders. 24: S10. DOI: 10.1016/S0960-8966(14)70029-X |
0.637 |
|
| 2014 |
Tinsley J, Bracchi A, Wilson F, Horne G, Robinson N, Fairclough R, Davies K. P10 Utrophin modulators to treat Duchenne Muscular Dystrophy (DMD): Future clinical trial plans for SMT C1100 and biomarker development programme Neuromuscular Disorders. 24: S9. DOI: 10.1016/S0960-8966(14)70026-4 |
0.575 |
|
| 2014 |
Fairclough R, Guiraud S, Squire S, Babbs A, Edward B, Shah N, Bracchi A, Wilson F, Horne G, Robinson N, Araujo N, Hewings D, Vuorinen A, Davies S, Wynne G, ... ... Davies K, et al. G.P.89 Neuromuscular Disorders. 24: 821. DOI: 10.1016/J.Nmd.2014.06.103 |
0.638 |
|
| 2013 |
Ravenscroft G, McNamara E, Griffiths LM, Papadimitriou JM, Hardeman EC, Bakker AJ, Davies KE, Laing NG, Nowak KJ. Cardiac α-actin over-expression therapy in dominant ACTA1 disease. Human Molecular Genetics. 22: 3987-97. PMID 23736297 DOI: 10.1093/hmg/ddt252 |
0.339 |
|
| 2013 |
Fairclough RJ, Wood MJ, Davies KE. Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nature Reviews. Genetics. 14: 373-8. PMID 23609411 DOI: 10.1038/Nrg3460 |
0.627 |
|
| 2013 |
Tremblay JP, Xiao X, Aartsma-Rus A, Barbas C, Blau HM, Bogdanove AJ, Boycott K, Braun S, Breakefield XO, Bueren JA, Buschmann M, Byrne BJ, Calos M, Cathomen T, Chamberlain J, ... ... Davies KE, et al. Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 266-8. PMID 23369965 DOI: 10.1038/Mt.2013.4 |
0.325 |
|
| 2013 |
Sleigh JN, Grice SJ, Davies KE, Talbot K. Spinal muscular atrophy at the crossroads of basic science and therapy. Neuromuscular Disorders : Nmd. 23: 96. PMID 22981697 DOI: 10.1016/J.Nmd.2012.08.008 |
0.794 |
|
| 2013 |
Tinsley J, Robinson N, Wilson F, Horne G, Fairclough R, Davies K. P.13.14 Future clinical and biomarker development for SMTC1100, the first utrophin modulator to enter clinical trials for Duchenne Muscular Dystrophy (DMD) Neuromuscular Disorders. 23: 813. DOI: 10.1016/J.Nmd.2013.06.608 |
0.616 |
|
| 2012 |
Eckenfelder A, Tordo J, Babbs A, Davies KE, Goyenvalle A, Danos O. The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery. Molecular Therapy. Nucleic Acids. 1: e31. PMID 23344083 DOI: 10.1038/Mtna.2012.24 |
0.353 |
|
| 2012 |
Oliver PL, Davies KE. New insights into behaviour using mouse ENU mutagenesis. Human Molecular Genetics. 21: R72-81. PMID 22892373 DOI: 10.1093/Hmg/Dds318 |
0.778 |
|
| 2012 |
Fairclough RJ, Perkins KJ, Davies KE. Pharmacologically targeting the primary defect and downstream pathology in Duchenne muscular dystrophy. Current Gene Therapy. 12: 206-44. PMID 22571500 DOI: 10.2174/156652312800840595 |
0.64 |
|
| 2012 |
Pritchett D, Wulff K, Oliver PL, Bannerman DM, Davies KE, Harrison PJ, Peirson SN, Foster RG. Evaluating the links between schizophrenia and sleep and circadian rhythm disruption. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 1061-75. PMID 22569850 DOI: 10.1007/S00702-012-0817-8 |
0.716 |
|
| 2012 |
Gehrig SM, van der Poel C, Sayer TA, Schertzer JD, Henstridge DC, Church JE, Lamon S, Russell AP, Davies KE, Febbraio MA, Lynch GS. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature. 484: 394-8. PMID 22495301 DOI: 10.1038/nature10980 |
0.327 |
|
| 2012 |
Goyenvalle A, Babbs A, Wright J, Wilkins V, Powell D, Garcia L, Davies KE. Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping. Human Molecular Genetics. 21: 2559-71. PMID 22388933 DOI: 10.1093/hmg/dds082 |
0.387 |
|
| 2012 |
Goyenvalle A, Wright J, Babbs A, Wilkins V, Garcia L, Davies KE. Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1212-21. PMID 22354379 DOI: 10.1038/mt.2012.26 |
0.376 |
|
| 2012 |
Oliver PL, Sobczyk MV, Maywood ES, Edwards B, Lee S, Livieratos A, Oster H, Butler R, Godinho SI, Wulff K, Peirson SN, Fisher SP, Chesham JE, Smith JW, Hastings MH, ... Davies KE, et al. Disrupted circadian rhythms in a mouse model of schizophrenia. Current Biology : Cb. 22: 314-9. PMID 22264613 DOI: 10.1016/J.Cub.2011.12.051 |
0.772 |
|
| 2012 |
Tan SC, Carr CA, Yeoh KK, Schofield CJ, Davies KE, Clarke K. Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors. Molecular Biology Reports. 39: 4857-67. PMID 22065248 DOI: 10.1007/S11033-011-1281-5 |
0.322 |
|
| 2012 |
Fairclough R, Squire S, Potter A, Powell D, Davies S, Bataille C, Wynne G, Russell A, Davies K. O01 Identification of new chemical compounds with upregulate utrophin for the therapy of Duchenne muscular dystrophy Neuromuscular Disorders. 22: S3. DOI: 10.1016/S0960-8966(12)00071-5 |
0.567 |
|
| 2012 |
Goyenvalle A, Babbs A, Avril A, Griffiths G, Dugovic B, Davies KE, Leumann C, Garcia L. Tricyclo-DNA: A promising chemistry for the synthesis of antisense molecules for splice-switching approaches in DMD Neuromuscular Disorders. 22: 907-907. DOI: 10.1016/J.Nmd.2012.06.340 |
0.341 |
|
| 2011 |
Ravenscroft G, Jackaman C, Sewry CA, McNamara E, Squire SE, Potter AC, Papadimitriou J, Griffiths LM, Bakker AJ, Davies KE, Laing NG, Nowak KJ. Actin nemaline myopathy mouse reproduces disease, suggests other actin disease phenotypes and provides cautionary note on muscle transgene expression. Plos One. 6: e28699. PMID 22174871 DOI: 10.1371/journal.pone.0028699 |
0.369 |
|
| 2011 |
Oliver PL, Finelli MJ, Edwards B, Bitoun E, Butts DL, Becker EB, Cheeseman MT, Davies B, Davies KE. Oxr1 is essential for protection against oxidative stress-induced neurodegeneration. Plos Genetics. 7: e1002338. PMID 22028674 DOI: 10.1371/Journal.Pgen.1002338 |
0.777 |
|
| 2011 |
Fairclough RJ, Bareja A, Davies KE. Progress in therapy for Duchenne muscular dystrophy. Experimental Physiology. 96: 1101-13. PMID 21804140 DOI: 10.1113/Expphysiol.2010.053025 |
0.647 |
|
| 2011 |
Vernes SC, Oliver PL, Spiteri E, Lockstone HE, Puliyadi R, Taylor JM, Ho J, Mombereau C, Brewer A, Lowy E, Nicod J, Groszer M, Baban D, Sahgal N, Cazier JB, ... ... Davies KE, et al. Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain. Plos Genetics. 7: e1002145. PMID 21765815 DOI: 10.1371/Journal.Pgen.1002145 |
0.796 |
|
| 2011 |
Tinsley JM, Fairclough RJ, Storer R, Wilkes FJ, Potter AC, Squire SE, Powell DS, Cozzoli A, Capogrosso RF, Lambert A, Wilson FX, Wren SP, De Luca A, Davies KE. Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse. Plos One. 6: e19189. PMID 21573153 DOI: 10.1371/Journal.Pone.0019189 |
0.625 |
|
| 2011 |
Pichavant C, Aartsma-Rus A, Clemens PR, Davies KE, Dickson G, Takeda S, Wilton SD, Wolff JA, Wooddell CI, Xiao X, Tremblay JP. Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 830-40. PMID 21468001 DOI: 10.1038/Mt.2011.59 |
0.369 |
|
| 2011 |
Goyenvalle A, Seto JT, Davies KE, Chamberlain J. Therapeutic approaches to muscular dystrophy. Human Molecular Genetics. 20: R69-78. PMID 21436158 DOI: 10.1093/Hmg/Ddr105 |
0.367 |
|
| 2011 |
Becker EB, Fogel BL, Rajakulendran S, Dulneva A, Hanna MG, Perlman SL, Geschwind DH, Davies KE. Candidate screening of the TRPC3 gene in cerebellar ataxia. Cerebellum (London, England). 10: 296-9. PMID 21321808 DOI: 10.1007/S12311-011-0253-6 |
0.795 |
|
| 2011 |
Ravenscroft G, Jackaman C, Bringans S, Papadimitriou JM, Griffiths LM, McNamara E, Bakker AJ, Davies KE, Laing NG, Nowak KJ. Mouse models of dominant ACTA1 disease recapitulate human disease and provide insight into therapies. Brain : a Journal of Neurology. 134: 1101-15. PMID 21303860 DOI: 10.1093/brain/awr004 |
0.385 |
|
| 2011 |
Goyenvalle A, Davies KE. Engineering exon-skipping vectors expressing U7 snRNA constructs for Duchenne muscular dystrophy gene therapy. Methods in Molecular Biology (Clifton, N.J.). 709: 179-96. PMID 21194028 DOI: 10.1007/978-1-61737-982-6_11 |
0.387 |
|
| 2011 |
Crisp A, Yin H, Goyenvalle A, Betts C, Moulton HM, Seow Y, Babbs A, Merritt T, Saleh AF, Gait MJ, Stuckey DJ, Clarke K, Davies KE, Wood MJ. Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Human Molecular Genetics. 20: 413-21. PMID 21062902 DOI: 10.1093/hmg/ddq477 |
0.316 |
|
| 2011 |
Fairclough R, Powell D, Squire S, Potter A, Bareja A, Russell A, Davies S, Davies K. P05 Utrophin upregulation in DMD therapy: current status and new tools for the future Neuromuscular Disorders. 21: S8. DOI: 10.1016/S0960-8966(11)70024-4 |
0.568 |
|
| 2010 |
Chodroff RA, Goodstadt L, Sirey TM, Oliver PL, Davies KE, Green ED, Molnár Z, Ponting CP. Long noncoding RNA genes: conservation of sequence and brain expression among diverse amniotes. Genome Biology. 11: R72. PMID 20624288 DOI: 10.1186/Gb-2010-11-7-R72 |
0.77 |
|
| 2010 |
Clarke WT, Edwards B, McCullagh KJ, Kemp MW, Moorwood C, Sherman DL, Burgess M, Davies KE. Syncoilin modulates peripherin filament networks and is necessary for large-calibre motor neurons. Journal of Cell Science. 123: 2543-52. PMID 20587592 DOI: 10.1242/jcs.059113 |
0.674 |
|
| 2010 |
Li D, Bareja A, Judge L, Yue Y, Lai Y, Fairclough R, Davies KE, Chamberlain JS, Duan D. Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. Journal of Cell Science. 123: 2008-13. PMID 20483958 DOI: 10.1242/Jcs.064808 |
0.638 |
|
| 2010 |
Turner BJ, Ackerley S, Davies KE, Talbot K. Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice. Human Molecular Genetics. 19: 815-24. PMID 20008901 DOI: 10.1093/Hmg/Ddp550 |
0.712 |
|
| 2010 |
Goyenvalle A, Babbs A, Powell D, Kole R, Fletcher S, Wilton SD, Davies KE. Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 198-205. PMID 19844193 DOI: 10.1038/mt.2009.248 |
0.397 |
|
| 2010 |
Fairclough R, Davies K. P25 Utrophin luciferase knock-in mouse model for in vivo assessment of drug efficacy in preclinical trials for utrophin upregulation Neuromuscular Disorders. 20: S12. DOI: 10.1016/S0960-8966(10)70040-7 |
0.576 |
|
| 2010 |
Bareja A, Fairclough R, Potter A, Powell D, Squire S, Davies K. P23 Assessing the effects of exercise-induced stress on the Fiona mouse model Neuromuscular Disorders. 20: S11. DOI: 10.1016/S0960-8966(10)70038-9 |
0.567 |
|
| 2009 |
Bäumer D, Lee S, Nicholson G, Davies JL, Parkinson NJ, Murray LM, Gillingwater TH, Ansorge O, Davies KE, Talbot K. Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. Plos Genetics. 5: e1000773. PMID 20019802 DOI: 10.1371/Journal.Pgen.1000773 |
0.739 |
|
| 2009 |
Bitoun E, Finelli MJ, Oliver PL, Lee S, Davies KE. AF4 is a critical regulator of the IGF-1 signaling pathway during Purkinje cell development. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 15366-74. PMID 20007461 DOI: 10.1523/Jneurosci.5188-09.2009 |
0.786 |
|
| 2009 |
Oliver PL, Davies KE. Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk. Human Molecular Genetics. 18: 4576-89. PMID 19729413 DOI: 10.1093/Hmg/Ddp425 |
0.757 |
|
| 2009 |
Davies K, Wynshaw-Boris A. Human genetics: conceptual and practical advances in the post-genome era Current Opinion in Genetics and Development. 19: 193-195. PMID 19481439 DOI: 10.1016/J.Gde.2009.05.002 |
0.379 |
|
| 2009 |
Nowak KJ, Ravenscroft G, Jackaman C, Filipovska A, Davies SM, Lim EM, Squire SE, Potter AC, Baker E, Clément S, Sewry CA, Fabian V, Crawford K, Lessard JL, Griffiths LM, ... ... Davies KE, et al. Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actin. The Journal of Cell Biology. 185: 903-15. PMID 19468071 DOI: 10.1083/jcb.200812132 |
0.311 |
|
| 2009 |
Goyenvalle A, Babbs A, van Ommen GJ, Garcia L, Davies KE. Enhanced exon-skipping induced by U7 snRNA carrying a splicing silencer sequence: Promising tool for DMD therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1234-40. PMID 19455105 DOI: 10.1038/mt.2009.113 |
0.379 |
|
| 2009 |
Becker EB, Oliver PL, Glitsch MD, Banks GT, Achilli F, Hardy A, Nolan PM, Fisher EM, Davies KE. A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. Proceedings of the National Academy of Sciences of the United States of America. 106: 6706-11. PMID 19351902 DOI: 10.1073/Pnas.0810599106 |
0.807 |
|
| 2009 |
Bitoun E, Davies KE. The robotic mouse: understanding the role of AF4, a cofactor of transcriptional elongation and chromatin remodelling, in purkinje cell function. Cerebellum (London, England). 8: 175-83. PMID 19340490 DOI: 10.1007/S12311-009-0101-0 |
0.788 |
|
| 2009 |
Turner BJ, Parkinson NJ, Davies KE, Talbot K. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model. Neurobiology of Disease. 34: 511-7. PMID 19332122 DOI: 10.1016/J.Nbd.2009.03.005 |
0.737 |
|
| 2009 |
Kemp MW, Edwards B, Burgess M, Clarke WT, Nicholson G, Parry DA, Davies KE. Syncoilin isoform organization and differential expression in murine striated muscle. Journal of Structural Biology. 165: 196-203. PMID 19070665 DOI: 10.1016/j.jsb.2008.11.002 |
0.645 |
|
| 2009 |
Hoerder-Suabedissen A, Wang WZ, Lee S, Davies KE, Goffinet AM, Raki? S, Parnavelas J, Reim K, Nicoli? M, Paulsen O, Molnár Z. Novel markers reveal subpopulations of subplate neurons in the murine cerebral cortex. Cerebral Cortex (New York, N.Y. : 1991). 19: 1738-50. PMID 19008461 DOI: 10.1093/Cercor/Bhn195 |
0.528 |
|
| 2009 |
Briese M, Esmaeili B, Fraboulet S, Burt EC, Christodoulou S, Towers PR, Davies KE, Sattelle DB. Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan. Human Molecular Genetics. 18: 97-104. PMID 18829666 DOI: 10.1093/hmg/ddn320 |
0.607 |
|
| 2008 |
Cauchi RJ, Davies KE, Liu JL. A motor function for the DEAD-box RNA helicase, Gemin3, in Drosophila. Plos Genetics. 4: e1000265. PMID 19023405 DOI: 10.1371/Journal.Pgen.1000265 |
0.717 |
|
| 2008 |
Vernes SC, Newbury DF, Abrahams BS, Winchester L, Nicod J, Groszer M, Alarcón M, Oliver PL, Davies KE, Geschwind DH, Monaco AP, Fisher SE. A functional genetic link between distinct developmental language disorders. The New England Journal of Medicine. 359: 2337-45. PMID 18987363 DOI: 10.1056/Nejmoa0802828 |
0.766 |
|
| 2008 |
Johnson RD, Oliver PL, Davies KE. SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses. Acta Biochimica Polonica. 55: 619-28. PMID 18985177 DOI: 10.18388/Abp.2008_3022 |
0.725 |
|
| 2008 |
McCullagh KJ, Edwards B, Kemp MW, Giles LC, Burgess M, Davies KE. Analysis of skeletal muscle function in the C57BL6/SV129 syncoilin knockout mouse. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 19: 339-51. PMID 18594912 DOI: 10.1007/s00335-008-9120-2 |
0.514 |
|
| 2008 |
Doran G, Davies KE, Talbot K. Activation of mutant protein kinase Cgamma leads to aberrant sequestration and impairment of its cellular function. Biochemical and Biophysical Research Communications. 372: 447-53. PMID 18503760 DOI: 10.1016/J.Bbrc.2008.05.072 |
0.708 |
|
| 2008 |
Talbot K, Davies KE. Is good housekeeping the key to motor neuron survival? Cell. 133: 572-4. PMID 18485864 DOI: 10.1016/J.Cell.2008.05.002 |
0.709 |
|
| 2008 |
Gulston MK, Rubtsov DV, Atherton HJ, Clarke K, Davies KE, Lilley KS, Griffin JL. A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart. Journal of Proteome Research. 7: 2069-77. PMID 18386883 DOI: 10.1021/pr800070p |
0.304 |
|
| 2008 |
Baban D, Davies KE. Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency. Neuromuscular Disorders : Nmd. 18: 239-47. PMID 18343112 DOI: 10.1016/j.nmd.2007.11.011 |
0.366 |
|
| 2008 |
't Hoen PA, de Meijer EJ, Boer JM, Vossen RH, Turk R, Maatman RG, Davies KE, van Ommen GJ, van Deutekom JC, den Dunnen JT. Generation and characterization of transgenic mice with the full-length human DMD gene. The Journal of Biological Chemistry. 283: 5899-907. PMID 18083704 DOI: 10.1074/jbc.M709410200 |
0.372 |
|
| 2008 |
Fairclough R, Potter A, Powell D, Squire S, Bland M, Bareja A, Tinsley J, Davies K. T.P.4.02 Evaluation of novel compounds for upregulation of utrophin in animal models of Duchenne muscular dystrophy therapy Neuromuscular Disorders. 18: 812. DOI: 10.1016/J.Nmd.2008.06.302 |
0.575 |
|
| 2008 |
Willmann R, Rüegg M, Fairclough R, Davies K, Possekel S, Meier T. T.P.3.03 TREAT-NMD-Activity 7: Accelerate preclinical phase of new therapeutic treatment development Neuromuscular Disorders. 18: 794. DOI: 10.1016/J.Nmd.2008.06.242 |
0.566 |
|
| 2008 |
Nowak KJ, Ravenscroft G, Jackaman C, Lim EM, Sewry CA, Potter A, Squire S, Fisher R, Baker E, Feng JJ, Marston S, Fabian V, Morling PJ, Bakker AJ, Griffiths LM, ... ... Davies KE, et al. A mutant skeletal muscle alpha-actin gene, fused to enhanced green fluorescent protein (EGFP) produces a unique myopathic mouse model Neuromuscular Disorders. 18: 785-786. DOI: 10.1016/J.Nmd.2008.06.213 |
0.325 |
|
| 2007 |
Kemp MW, Davies KE. The role of intermediate filament proteins in the development of neurological disease. Critical Reviews in Neurobiology. 19: 1-27. PMID 19166389 DOI: 10.1615/Critrevneurobiol.V19.I1.10 |
0.365 |
|
| 2007 |
Talbot K, Davies KE. Chapter 7 Spinal muscular atrophies and hereditary motor neuropathies. Handbook of Clinical Neurology. 82: 141-53. PMID 18808892 DOI: 10.1016/S0072-9752(07)80010-8 |
0.712 |
|
| 2007 |
Molnár Z, Hoerder-Suabedissen A, Wang WZ, DeProto J, Davies K, Lee S, Jacobs EC, Campagnoni AT, Paulsen O, Piñon MC, Cheung AF. Genes involved in the formation of the earliest cortical circuits. Novartis Foundation Symposium. 288: 212-24; discussion 2. PMID 18494261 DOI: 10.1016/J.Ijdevneu.2012.10.031 |
0.461 |
|
| 2007 |
Vernes SC, Spiteri E, Nicod J, Groszer M, Taylor JM, Davies KE, Geschwind DH, Fisher SE. High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. American Journal of Human Genetics. 81: 1232-50. PMID 17999362 DOI: 10.1086/522238 |
0.553 |
|
| 2007 |
Trülzsch B, Garnett C, Davies K, Wood M. Knockdown of SMN by RNA interference induces apoptosis in differentiated P19 neural stem cells. Brain Research. 1183: 1-9. PMID 17976539 DOI: 10.1016/j.brainres.2007.09.025 |
0.37 |
|
| 2007 |
Mattei E, Corbi N, Di Certo MG, Strimpakos G, Severini C, Onori A, Desantis A, Libri V, Buontempo S, Floridi A, Fanciulli M, Baban D, Davies KE, Passananti C. Utrophin up-regulation by an artificial transcription factor in transgenic mice. Plos One. 2: e774. PMID 17712422 DOI: 10.1371/journal.pone.0000774 |
0.385 |
|
| 2007 |
McCullagh KJ, Edwards B, Poon E, Lovering RM, Paulin D, Davies KE. Intermediate filament-like protein syncoilin in normal and myopathic striated muscle. Neuromuscular Disorders : Nmd. 17: 970-9. PMID 17629480 DOI: 10.1016/j.nmd.2007.06.004 |
0.508 |
|
| 2007 |
Oliver PL, Keays DA, Davies KE. Behavioural characterisation of the robotic mouse mutant. Behavioural Brain Research. 181: 239-47. PMID 17532061 DOI: 10.1016/J.Bbr.2007.04.012 |
0.74 |
|
| 2007 |
Oliver PL, Bitoun E, Davies KE. Comparative genetic analysis: the utility of mouse genetic systems for studying human monogenic disease. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 18: 412-24. PMID 17514509 DOI: 10.1007/S00335-007-9014-8 |
0.808 |
|
| 2007 |
Rezniczek GA, Konieczny P, Nikolic B, Reipert S, Schneller D, Abrahamsberg C, Davies KE, Winder SJ, Wiche G. Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. The Journal of Cell Biology. 176: 965-77. PMID 17389230 DOI: 10.1083/jcb.200604179 |
0.305 |
|
| 2007 |
Li Y, Huang J, Zhao YL, He J, Wang W, Davies KE, Nosé V, Xiao S. UTRN on chromosome 6q24 is mutated in multiple tumors. Oncogene. 26: 6220-8. PMID 17384672 DOI: 10.1038/sj.onc.1210432 |
0.331 |
|
| 2007 |
Jeans AF, Oliver PL, Johnson R, Capogna M, Vikman J, Molnár Z, Babbs A, Partridge CJ, Salehi A, Bengtsson M, Eliasson L, Rorsman P, Davies KE. A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proceedings of the National Academy of Sciences of the United States of America. 104: 2431-6. PMID 17283335 DOI: 10.1073/Pnas.0610222104 |
0.792 |
|
| 2007 |
Keays DA, Tian G, Poirier K, Huang GJ, Siebold C, Cleak J, Oliver PL, Fray M, Harvey RJ, Molnár Z, Piñon MC, Dear N, Valdar W, Brown SD, Davies KE, et al. Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell. 128: 45-57. PMID 17218254 DOI: 10.1016/J.Cell.2006.12.017 |
0.794 |
|
| 2007 |
Bitoun E, Oliver PL, Davies KE. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Human Molecular Genetics. 16: 92-106. PMID 17135274 DOI: 10.1093/Hmg/Ddl444 |
0.782 |
|
| 2006 |
Vernes SC, Nicod J, Elahi FM, Coventry JA, Kenny N, Coupe AM, Bird LE, Davies KE, Fisher SE. Functional genetic analysis of mutations implicated in a human speech and language disorder. Human Molecular Genetics. 15: 3154-67. PMID 16984964 DOI: 10.1093/Hmg/Ddl392 |
0.549 |
|
| 2006 |
Davies KE, Nowak KJ. Molecular mechanisms of muscular dystrophies: old and new players. Nature Reviews. Molecular Cell Biology. 7: 762-73. PMID 16971897 DOI: 10.1038/nrm2024 |
0.36 |
|
| 2006 |
Towers PR, Lescure P, Baban D, Malek JA, Duarte J, Jones E, Davies KE, Ségalat L, Sattelle DB. Gene expression profiling studies on Caenorhabditis elegans dystrophin mutants dys-1(cx-35) and dys-1(cx18). Genomics. 88: 642-9. PMID 16962739 DOI: 10.1016/j.ygeno.2006.07.014 |
0.584 |
|
| 2006 |
Jiang Y, Oliver P, Davies KE, Platt N. Identification and characterization of murine SCARA5, a novel class A scavenger receptor that is expressed by populations of epithelial cells. The Journal of Biological Chemistry. 281: 11834-45. PMID 16407294 DOI: 10.1074/Jbc.M507599200 |
0.72 |
|
| 2006 |
Ackerley S, James PA, Kalli A, French S, Davies KE, Talbot K. A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Human Molecular Genetics. 15: 347-54. PMID 16368711 DOI: 10.1093/Hmg/Ddi452 |
0.715 |
|
| 2005 |
Bitoun E, Davies KE. The robotic mouse: unravelling the function of AF4 in the cerebellum. Cerebellum (London, England). 4: 250-60. PMID 16321881 DOI: 10.1080/14734220500325897 |
0.781 |
|
| 2005 |
Brown SC, Torelli S, Ugo I, De Biasia F, Howman EV, Poon E, Britton J, Davies KE, Muntoni F. Syncoilin upregulation in muscle of patients with neuromuscular disease. Muscle & Nerve. 32: 715-25. PMID 16124004 DOI: 10.1002/mus.20431 |
0.32 |
|
| 2005 |
Oliver PL, Davies KE. Analysis of human neurological disorders using mutagenesis in the mouse. Clinical Science (London, England : 1979). 108: 385-97. PMID 15831088 DOI: 10.1042/Cs20050041 |
0.782 |
|
| 2005 |
Nowak K, McCullagh K, Poon E, Davies KE. Muscular dystrophies related to the cytoskeleton/nuclear envelope. Novartis Foundation Symposium. 264: 98-111; discussion 1. PMID 15773750 DOI: 10.1002/0470093765.Ch8 |
0.373 |
|
| 2005 |
Jones GL, Sang E, Goddard C, Mortishire-Smith RJ, Sweatman BC, Haselden JN, Davies K, Grace AA, Clarke K, Griffin JL. A functional analysis of mouse models of cardiac disease through metabolic profiling. The Journal of Biological Chemistry. 280: 7530-9. PMID 15546876 DOI: 10.1074/jbc.M410200200 |
0.332 |
|
| 2004 |
Rastan S, Hough T, Kierman A, Hardisty R, Erven A, Gray IC, Voeling S, Isaacs A, Tsai H, Strivens M, Washbourne R, Thornton C, Greenaway S, Hewitt M, McCormick S, ... ... Davies K, et al. Towards a mutant map of the mouse--new models of neurological, behavioural, deafness, bone, renal and blood disorders. Genetica. 122: 47-9. PMID 15619960 DOI: 10.1007/S10709-004-1930-X |
0.359 |
|
| 2004 |
Moore CJ, Daly EM, Tassone F, Tysoe C, Schmitz N, Ng V, Chitnis X, McGuire P, Suckling J, Davies KE, Hagerman RJ, Hagerman PJ, Murphy KC, Murphy DG. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy. Brain : a Journal of Neurology. 127: 2672-81. PMID 15483045 DOI: 10.1093/Brain/Awh256 |
0.344 |
|
| 2004 |
Anderson KN, Baban D, Oliver PL, Potter A, Davies KE. Expression profiling in spinal muscular atrophy reveals an RNA binding protein deficit. Neuromuscular Disorders : Nmd. 14: 711-22. PMID 15482955 DOI: 10.1016/J.Nmd.2004.08.009 |
0.764 |
|
| 2004 |
Nowak KJ, Davies KE. Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. Embo Reports. 5: 872-6. PMID 15470384 DOI: 10.1038/sj.embor.7400221 |
0.391 |
|
| 2004 |
Oliver PL, Bitoun E, Clark J, Jones EL, Davies KE. Mediation of Af4 protein function in the cerebellum by Siah proteins. Proceedings of the National Academy of Sciences of the United States of America. 101: 14901-6. PMID 15459319 DOI: 10.1073/Pnas.0406196101 |
0.789 |
|
| 2004 |
Auwerx J, Avner P, Baldock R, Ballabio A, Balling R, Barbacid M, Berns A, Bradley A, Brown S, Carmeliet P, Chambon P, Cox R, Davidson D, Davies K, Duboule D, et al. The European dimension for the mouse genome mutagenesis program. Nature Genetics. 36: 925-7. PMID 15340424 DOI: 10.1038/Ng0904-925 |
0.326 |
|
| 2004 |
Ilkovski B, Nowak KJ, Domazetovska A, Maxwell AL, Clement S, Davies KE, Laing NG, North KN, Cooper ST. Evidence for a dominant-negative effect in ACTA1 nemaline myopathy caused by abnormal folding, aggregation and altered polymerization of mutant actin isoforms. Human Molecular Genetics. 13: 1727-43. PMID 15198992 DOI: 10.1093/Hmg/Ddh185 |
0.324 |
|
| 2004 |
Anderson KN, Potter AC, Piccenna LG, Quah AK, Davies KE, Cheema SS. Isolation and culture of motor neurons from the newborn mouse spinal cord. Brain Research. Brain Research Protocols. 12: 132-6. PMID 15013463 DOI: 10.1016/j.brainresprot.2003.10.001 |
0.325 |
|
| 2004 |
Trülzsch B, Davies K, Wood M. Survival of motor neuron gene downregulation by RNAi: towards a cell culture model of spinal muscular atrophy. Brain Research. Molecular Brain Research. 120: 145-50. PMID 14741404 DOI: 10.1016/J.MOLBRAINRES.2003.10.015 |
0.393 |
|
| 2004 |
Weir AP, Morgan JE, Davies KE. A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration. Neuromuscular Disorders : Nmd. 14: 19-23. PMID 14659408 DOI: 10.1016/j.nmd.2003.09.004 |
0.306 |
|
| 2003 |
Moghadaszadeh B, Albrechtsen R, Guo LT, Zaik M, Kawaguchi N, Borup RH, Kronqvist P, Schroder HD, Davies KE, Voit T, Nielsen FC, Engvall E, Wewer UM. Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins. Human Molecular Genetics. 12: 2467-79. PMID 12915458 DOI: 10.1093/hmg/ddg264 |
0.365 |
|
| 2003 |
Anderson K, Potter A, Baban D, Davies KE. Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology. Brain : a Journal of Neurology. 126: 2052-64. PMID 12847076 DOI: 10.1093/brain/awg208 |
0.405 |
|
| 2003 |
Talbot K, Davies K. Musculoskeletal diseases: from complex genetics to therapy. Current Opinion in Pharmacology. 3: 277-9. PMID 12810192 DOI: 10.1016/S1471-4892(03)00044-4 |
0.666 |
|
| 2003 |
Chan YB, Miguel-Aliaga I, Franks C, Thomas N, Trülzsch B, Sattelle DB, Davies KE, van den Heuvel M. Neuromuscular defects in a Drosophila survival motor neuron gene mutant. Human Molecular Genetics. 12: 1367-76. PMID 12783845 DOI: 10.1093/Hmg/Ddg157 |
0.611 |
|
| 2003 |
Khurana TS, Davies KE. Pharmacological strategies for muscular dystrophy. Nature Reviews. Drug Discovery. 2: 379-90. PMID 12750741 DOI: 10.1038/nrd1085 |
0.352 |
|
| 2003 |
Cerletti M, Negri T, Cozzi F, Colpo R, Andreetta F, Croci D, Davies KE, Cornelio F, Pozza O, Karpati G, Gilbert R, Mora M. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Therapy. 10: 750-7. PMID 12704413 DOI: 10.1038/sj.gt.3301941 |
0.361 |
|
| 2003 |
Isaacs AM, Oliver PL, Jones EL, Jeans A, Potter A, Hovik BH, Nolan PM, Vizor L, Glenister P, Simon AK, Gray IC, Spurr NK, Brown SD, Hunter AJ, Davies KE. A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 1631-7. PMID 12629167 DOI: 10.1523/Jneurosci.23-05-01631.2003 |
0.77 |
|
| 2003 |
Jimenez-Mallebrera C, Davies K, Putt W, Edwards YH. A study of short utrophin isoforms in mice deficient for full-length utrophin. Mammalian Genome. 14: 47-60. PMID 12532267 DOI: 10.1007/S00335-002-3044-Z |
0.349 |
|
| 2003 |
Anderson K, Pouting C, Potter A, Davies K. Motor Neurons and Microarrays-Understanding the Pathogenesis of Spinal Muscular Atrophy Clinical Science. 104: 40P-41P. DOI: 10.1042/CS104040PB |
0.317 |
|
| 2003 |
Trülzsch B, Davies K, Wood M. Characterisation of catalytic nucleic acids targeting the survival of motor neuron messenger RNA Neuroscience Research Communications. 32: 95-106. DOI: 10.1002/NRC.10064 |
0.381 |
|
| 2002 |
Squire S, Raymackers JM, Vandebrouck C, Potter A, Tinsley J, Fisher R, Gillis JM, Davies KE. Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Human Molecular Genetics. 11: 3333-44. PMID 12471059 DOI: 10.1093/Hmg/11.26.3333 |
0.335 |
|
| 2002 |
Griffin JL, Sang E, Evens T, Davies K, Clarke K. Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy. Febs Letters. 530: 109-116. PMID 12387876 DOI: 10.1016/S0014-5793(02)03437-3 |
0.315 |
|
| 2002 |
Isaacs AM, Jeans A, Oliver PL, Vizor L, Brown SD, Hunter AJ, Davies KE. Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy. Molecular and Cellular Neurosciences. 21: 114-25. PMID 12359155 DOI: 10.1042/Cs104041P |
0.762 |
|
| 2002 |
Weir AP, Burton EA, Harrod G, Davies KE. A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle. The Journal of Biological Chemistry. 277: 45285-90. PMID 12235137 DOI: 10.1074/jbc.M205177200 |
0.319 |
|
| 2002 |
Perkins KJ, Davies KE. The role of utrophin in the potential therapy of Duchenne muscular dystrophy. Neuromuscular Disorders : Nmd. 12: S78-89. PMID 12206801 DOI: 10.1016/S0960-8966(02)00087-1 |
0.396 |
|
| 2002 |
Vargas JD, Culetto E, Ponting CP, Miguel-Aliaga I, Davies KE, Sattelle DB. Cloning and developmental expression analysis of ltd-1, the Caenorhabditis elegans homologue of the mouse kyphoscoliosis (ky) gene. Mechanisms of Development. 117: 289-92. PMID 12204272 DOI: 10.1016/S0925-4773(02)00182-X |
0.561 |
|
| 2002 |
Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiological Reviews. 82: 291-329. PMID 11917091 DOI: 10.1152/physrev.00028.2001 |
0.351 |
|
| 2002 |
Poon E, Howman EV, Newey SE, Davies KE. Association of syncoilin and desmin: linking intermediate filament proteins to the dystrophin-associated protein complex. The Journal of Biological Chemistry. 277: 3433-9. PMID 11694502 DOI: 10.1074/jbc.M105273200 |
0.316 |
|
| 2001 |
Culle MJ, Walsh JM, Tinsle JM, Fisher R, Davies KE. Immunogold confirmation that utrophin is localized to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle. The Histochemical Journal. 33: 579-83. PMID 12005030 DOI: 10.1023/A:1014964127156 |
0.323 |
|
| 2001 |
Perkins KJ, Burton EA, Davies KE. The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy. Nucleic Acids Research. 29: 4843-50. PMID 11726694 DOI: 10.1093/Nar/29.23.4843 |
0.343 |
|
| 2001 |
Fisher R, Tinsley JM, Phelps SR, Squire SE, Townsend ER, Martin JE, Davies KE. Non-toxic ubiquitous over-expression of utrophin in the mdx mouse. Neuromuscular Disorders : Nmd. 11: 713-21. PMID 11595513 DOI: 10.1016/S0960-8966(01)00220-6 |
0.371 |
|
| 2001 |
Talbot K, Davies KE. Spinal muscular atrophy. Seminars in Neurology. 21: 189-97. PMID 11442327 DOI: 10.1055/S-2001-15264 |
0.735 |
|
| 2001 |
Skordis LA, Dunckley MG, Burglen L, Campbell L, Talbot K, Patel S, Melki J, Davies KE, Dubowitz V, Muntoni F. Characterisation of novel point mutations in the survival motor neuron gene SMN, in three patients with SMA. Human Genetics. 108: 356-7. PMID 11379882 DOI: 10.1007/S004390100497 |
0.721 |
|
| 2001 |
Nakamura A, Harrod GV, Davies KE. Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice. Neuromuscular Disorders : Nmd. 11: 251-9. PMID 11297940 DOI: 10.1016/S0960-8966(00)00201-7 |
0.317 |
|
| 2000 |
Hopkins JC, Bia BL, Crilley JG, Boehm EA, Sang AE, Tinsley JM, King LM, Radda GK, Davies KE, Clarke K. Muscular dystrophy: from gene to patient. Magma (New York, N.Y.). 11: 7-9. PMID 11186993 DOI: 10.1007/Bf02678481 |
0.32 |
|
| 2000 |
Miguel-Aliaga I, Chan YB, Davies KE, van den Heuvel M. Disruption of SMN function by ectopic expression of the human SMN gene in Drosophila. Febs Letters. 486: 99-102. PMID 11113446 DOI: 10.1016/S0014-5793(00)02243-2 |
0.418 |
|
| 2000 |
Newey SE, Benson MA, Ponting CP, Davies KE, Blake DJ. Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex. Current Biology : Cb. 10: 1295-8. PMID 11069112 DOI: 10.1016/S0960-9822(00)00760-0 |
0.316 |
|
| 2000 |
Rafael JA, Nitta Y, Peters J, Davies KE. Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 11: 725-8. PMID 10967129 DOI: 10.1007/s003350010149 |
0.32 |
|
| 2000 |
Nolan PM, Peters J, Strivens M, Rogers D, Hagan J, Spurr N, Gray IC, Vizor L, Brooker D, Whitehill E, Washbourne R, Hough T, Greenaway S, Hewitt M, Liu X, ... ... Davies K, et al. A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nature Genetics. 25: 440-3. PMID 10932191 DOI: 10.1038/78140 |
0.381 |
|
| 2000 |
Isaacs AM, Davies KE, Hunter AJ, Nolan PM, Vizor L, Peters J, Gale DG, Kelsell DP, Latham ID, Chase JM, Fisher EM, Bouzyk MM, Potter A, Masih M, Walsh FS, et al. Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Human Molecular Genetics. 9: 1865-71. PMID 10915775 DOI: 10.1046/J.1529-8027.2001.01008-19.X |
0.396 |
|
| 2000 |
Corbi N, Libri V, Fanciulli M, Tinsley JM, Davies KE, Passananti C. The artificial zinc finger coding gene 'Jazz' binds the utrophin promoter and activates transcription. Gene Therapy. 7: 1076-83. PMID 10871758 DOI: 10.1038/sj.gt.3301204 |
0.32 |
|
| 2000 |
Rafael JA, Townsend ER, Squire SE, Potter AC, Chamberlain JS, Davies KE. Dystrophin and utrophin influence fiber type composition and post-synaptic membrane structure. Human Molecular Genetics. 9: 1357-67. PMID 10814717 DOI: 10.1093/HMG/9.9.1357 |
0.348 |
|
| 2000 |
Rodrigues NR, Theodosiou AM, Nesbit MA, Campbell L, Tandle AT, Saranath D, Davies KE. Characterization of Ngef, a novel member of the Dbl family of genes expressed predominantly in the caudate nucleus. Genomics. 65: 53-61. PMID 10777665 DOI: 10.1006/geno.2000.6138 |
0.356 |
|
| 2000 |
Campbell L, Hunter KM, Mohaghegh P, Tinsley JM, Brasch MA, Davies KE. Direct interaction of Smn with dp103, a putative RNA helicase: a role for Smn in transcription regulation? Human Molecular Genetics. 9: 1093-100. PMID 10767334 DOI: 10.1093/Hmg/9.7.1093 |
0.43 |
|
| 2000 |
Owen N, Doe CL, Mellor J, Davies KE. Characterization of the Schizosaccharomyces pombe orthologue of the human survival motor neuron (SMN) protein. Human Molecular Genetics. 9: 675-84. PMID 10749974 DOI: 10.1093/Hmg/9.5.675 |
0.434 |
|
| 2000 |
Wakefield PM, Tinsley JM, Wood MJ, Gilbert R, Karpati G, Davies KE. Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Therapy. 7: 201-4. PMID 10694796 DOI: 10.1038/sj.gt.3301066 |
0.34 |
|
| 2000 |
Miller WJ, Skinner JA, Foss GS, Davies KE. Localization of the fragile X mental retardation 2 (FMR2) protein in mammalian brain. The European Journal of Neuroscience. 12: 381-4. PMID 10651894 DOI: 10.1046/j.1460-9568.2000.00921.x |
0.342 |
|
| 1999 |
Burton EA, Tinsley JM, Holzfeind PJ, Rodrigues NR, Davies KE. A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. 96: 14025-30. PMID 10570192 DOI: 10.1073/Pnas.96.24.14025 |
0.351 |
|
| 1999 |
Miguel-Aliaga I, Culetto E, Walker DS, Baylis HA, Sattelle DB, Davies KE. The Caenorhabditis elegans orthologue of the human gene responsible for spinal muscular atrophy is a maternal product critical for germline maturation and embryonic viability. Human Molecular Genetics. 8: 2133-43. PMID 10545592 DOI: 10.1093/Hmg/8.12.2133 |
0.618 |
|
| 1999 |
Bia BL, Cassidy PJ, Young ME, Rafael JA, Leighton B, Davies KE, Radda GK, Clarke K. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. Journal of Molecular and Cellular Cardiology. 31: 1857-62. PMID 10525423 DOI: 10.1006/Jmcc.1999.1018 |
0.319 |
|
| 1999 |
Mohaghegh P, Rodrigues NR, Owen N, Ponting CP, Le TT, Burghes AH, Davies KE. Analysis of mutations in the tudor domain of the survival motor neuron protein SMN. European Journal of Human Genetics : Ejhg. 7: 519-25. PMID 10439956 DOI: 10.1038/Sj.Ejhg.5200346 |
0.407 |
|
| 1999 |
Gilbert R, Nalbantoglu J, Petrof BJ, Ebihara S, Guibinga GH, Tinsley JM, Kamen A, Massie B, Davies KE, Karpati G. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Human Gene Therapy. 10: 1299-310. PMID 10365661 DOI: 10.1089/10430349950017987 |
0.355 |
|
| 1999 |
Rafael JA, Trickett JI, Potter AC, Davies KE. Dystrophin and utrophin do not play crucial roles in nonmuscle tissues in mice. Muscle & Nerve. 22: 517-9. PMID 10204788 DOI: 10.1002/(SICI)1097-4598(199904)22:4<517::AID-MUS14>3.0.CO;2-6 |
0.305 |
|
| 1999 |
Gramolini AO, Angus LM, Schaeffer L, Burton EA, Tinsley JM, Davies KE, Changeux JP, Jasmin BJ. Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. Proceedings of the National Academy of Sciences of the United States of America. 96: 3223-7. PMID 10077665 DOI: 10.1073/Pnas.96.6.3223 |
0.355 |
|
| 1999 |
Holzfeind PJ, Ambrose HJ, Newey SE, Nawrotzki RA, Blake DJ, Davies KE. Tissue-selective expression of alpha-dystrobrevin is determined by multiple promoters. The Journal of Biological Chemistry. 274: 6250-8. PMID 10037712 DOI: 10.1074/jbc.274.10.6250 |
0.317 |
|
| 1998 |
Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nature Medicine. 4: 1441-4. PMID 9846586 DOI: 10.1038/4033 |
0.32 |
|
| 1998 |
Trump D, Dixon PH, Mumm S, Wooding C, Davies KE, Schlessinger D, Whyte MP, Thakker RV. Localisation of X linked recessive idiopathic hypoparathyroidism to a 1.5 Mb region on Xq26-q27. Journal of Medical Genetics. 35: 905-9. PMID 9832036 DOI: 10.1136/Jmg.35.11.905 |
0.302 |
|
| 1998 |
Talbot K, Miguel-Aliaga I, Mohaghegh P, Ponting CP, Davies KE. Characterization of a gene encoding survival motor neuron (SMN)-related protein, a constituent of the spliceosome complex. Human Molecular Genetics. 7: 2149-56. PMID 9817934 DOI: 10.1093/Hmg/7.13.2149 |
0.737 |
|
| 1998 |
Taylor JE, Thomas NH, Lewis CM, Abbs SJ, Rodrigues NR, Davies KE, Mathew CG. Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy. European Journal of Human Genetics : Ejhg. 6: 467-74. PMID 9801871 DOI: 10.1038/sj.ejhg.5200210 |
0.38 |
|
| 1998 |
Campbell L, Daniels RJ, Dubowitz V, Davies KE. Maternal mosaicism for a second mutational event in a type I spinal muscular atrophy family. American Journal of Human Genetics. 63: 37-44. PMID 9634516 DOI: 10.1086/301918 |
0.388 |
|
| 1998 |
Paulsen M, Davies KR, Bowden LM, Villar AJ, Franck O, Fuermann M, Dean WL, Moore TF, Rodrigues N, Davies KE, Hu RJ, Feinberg AP, Maher ER, Reik W, Walter J. Syntenic organization of the mouse distal chromosome 7 imprinting cluster and the Beckwith-Wiedemann syndrome region in chromosome 11p15.5. Human Molecular Genetics. 7: 1149-59. PMID 9618174 DOI: 10.1093/hmg/7.7.1149 |
0.344 |
|
| 1998 |
Vater R, Young C, Anderson LV, Lindsay S, Blake DJ, Davies KE, Zuellig R, Slater CR. Utrophin mRNA expression in muscle is not restricted to the neuromuscular junction. Molecular and Cellular Neurosciences. 10: 229-42. PMID 9604203 DOI: 10.1006/Mcne.1998.0661 |
0.304 |
|
| 1998 |
Rafael JA, Tinsley JM, Potter AC, Deconinck AE, Davies KE. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nature Genetics. 19: 79-82. PMID 9590295 DOI: 10.1038/ng0598-79 |
0.339 |
|
| 1998 |
Chakrabarti L, Bristulf J, Foss GS, Davies KE. Expression of the murine homologue of FMR2 in mouse brain and during development. Human Molecular Genetics. 7: 441-8. PMID 9467002 DOI: 10.1093/hmg/7.3.441 |
0.345 |
|
| 1998 |
Gilbert R, Nalbanoglu J, Tinsley JM, Massie B, Davies KE, Karpati G. Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle. Biochemical and Biophysical Research Communications. 242: 244-7. PMID 9439643 DOI: 10.1006/Bbrc.1997.7936 |
0.328 |
|
| 1998 |
Gramolini AO, Burton EA, Tinsley JM, Ferns MJ, Cartaud A, Cartaud J, Davies KE, Lunde JA, Jasmin BJ. Muscle and neural isoforms of agrin increase utrophin expression in cultured myotubes via a transcriptional regulatory mechanism. The Journal of Biological Chemistry. 273: 736-43. PMID 9422725 DOI: 10.1074/Jbc.273.2.736 |
0.368 |
|
| 1997 |
Davies KE. Challenges in Duchenne muscular dystrophy. Neuromuscular Disorders : Nmd. 7: 482-6. PMID 9447604 DOI: 10.1016/S0960-8966(97)00107-7 |
0.334 |
|
| 1997 |
Ritchie RJ, Chakrabarti L, Knight SJ, Harding RM, Davies KE. Population genetics of the FRAXE and FRAXF GCC repeats, and a novel CGG repeat, in Xq28. American Journal of Medical Genetics. 73: 463-9. PMID 9415475 DOI: 10.1002/(SICI)1096-8628(19971231)73:4<463::AID-AJMG16>3.0.CO;2-P |
0.318 |
|
| 1997 |
Deconinck N, Tinsley J, De Backer F, Fisher R, Kahn D, Phelps S, Davies K, Gillis JM. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nature Medicine. 3: 1216-21. PMID 9359695 DOI: 10.1038/NM1197-1216 |
0.323 |
|
| 1997 |
Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM, Davies KE. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 90: 717-27. PMID 9288751 DOI: 10.1016/S0092-8674(00)80532-2 |
0.352 |
|
| 1997 |
Campbell L, Potter A, Ignatius J, Dubowitz V, Davies K. Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. American Journal of Human Genetics. 61: 40-50. PMID 9245983 DOI: 10.1086/513886 |
0.411 |
|
| 1997 |
Metzinger L, Blake DJ, Squier MV, Anderson LV, Deconinck AE, Nawrotzki R, Hilton-Jones D, Davies KE. Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Human Molecular Genetics. 6: 1185-91. PMID 9215691 DOI: 10.1093/Hmg/6.7.1185 |
0.365 |
|
| 1997 |
Nesbit MA, Hodges MD, Campbell L, de Meulemeester TM, Alders M, Rodrigues NR, Talbot K, Theodosiou AM, Mannens MA, Nakamura Y, Little PF, Davies KE. Genomic organization and chromosomal localization of a member of the MAP kinase phosphatase gene family to human chromosome 11p15.5 and a pseudogene to 10q11.2. Genomics. 42: 284-94. PMID 9192849 DOI: 10.1006/Geno.1997.4737 |
0.696 |
|
| 1997 |
Talbot K, Rodrigues NR, Ignatius J, Muntoni F, Davies KE. Gene conversion at the SMN locus in autosomal recessive spinal muscular atrophy does not predict a mild phenotype. Neuromuscular Disorders : Nmd. 7: 198-201. PMID 9185185 DOI: 10.1016/S0960-8966(97)00450-1 |
0.736 |
|
| 1997 |
Talbot K, Ponting CP, Theodosiou AM, Rodrigues NR, Surtees R, Mountford R, Davies KE. Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism? Human Molecular Genetics. 6: 497-500. PMID 9147655 DOI: 10.1093/Hmg/6.3.497 |
0.727 |
|
| 1997 |
Ambrose HJ, Blake DJ, Nawrotzki RA, Davies KE. Genomic organization of the mouse dystrobrevin gene: comparative analysis with the dystrophin gene. Genomics. 39: 359-69. PMID 9119373 DOI: 10.1006/geno.1996.4515 |
0.378 |
|
| 1997 |
Gramolini AO, Dennis CL, Tinsley JM, Robertson GS, Cartaud J, Davies KE, Jasmin BJ. Local transcriptional control of utrophin expression at the neuromuscular synapse. The Journal of Biological Chemistry. 272: 8117-20. PMID 9079621 DOI: 10.1074/Jbc.272.13.8117 |
0.352 |
|
| 1997 |
Deconinck AE, Potter AC, Tinsley JM, Wood SJ, Vater R, Young C, Metzinger L, Vincent A, Slater CR, Davies KE. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. The Journal of Cell Biology. 136: 883-94. PMID 9049253 DOI: 10.1083/Jcb.136.4.883 |
0.333 |
|
| 1997 |
Barnicoat AJ, Wang Q, Turk J, Green E, Mathew CG, Flynn G, Buckle V, Hirst M, Davies K, Bobrow M. Clinical, cytogenetic, and molecular analysis of three families with FRAXE. Journal of Medical Genetics. 34: 13-17. PMID 9032643 DOI: 10.1136/Jmg.34.1.13 |
0.318 |
|
| 1996 |
Talbot K, Rodrigues N, Bernert G, Bittner R, Davies K. Evidence for compound heterozygosity causing mild and severe forms of autosomal recessive spinal muscular atrophy. Journal of Medical Genetics. 33: 1019-21. PMID 9004135 DOI: 10.1136/Jmg.33.12.1019 |
0.732 |
|
| 1996 |
Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, Davies KE. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature. 384: 349-53. PMID 8934518 DOI: 10.1038/384349a0 |
0.36 |
|
| 1996 |
Rodrigues NR, Owen N, Talbot K, Patel S, Muntoni F, Ignatius J, Dubowitz V, Davies KE. Gene deletions in spinal muscular atrophy. Journal of Medical Genetics. 33: 93-6. PMID 8929942 DOI: 10.1136/Jmg.33.2.93 |
0.72 |
|
| 1996 |
Blake DJ, Tinsley JM, Davies KE. Utrophin: a structural and functional comparison to dystrophin. Brain Pathology (Zurich, Switzerland). 6: 37-47. PMID 8866746 DOI: 10.1111/J.1750-3639.1996.Tb00781.X |
0.357 |
|
| 1996 |
Ponting CP, Blake DJ, Davies KE, Kendrick-Jones J, Winder SJ. ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends in Biochemical Sciences. 21: 11-13. PMID 8848831 DOI: 10.1016/S0968-0004(06)80020-4 |
0.327 |
|
| 1996 |
Rodrigues NR, Talbot K, Davies KE. Molecular genetics of autosomal recessive spinal muscular atrophy. Molecular Medicine (Cambridge, Mass.). 2: 400-4. PMID 8827710 DOI: 10.1007/Bf03401899 |
0.68 |
|
| 1996 |
Chakrabarti L, Knight SJ, Flannery AV, Davies KE. A candidate gene for mild mental handicap at the FRAXE fragile site. Human Molecular Genetics. 5: 275-82. PMID 8824884 DOI: 10.1093/hmg/5.2.275 |
0.325 |
|
| 1996 |
Coleman MP, Ambrose HJ, Carrel L, Németh AH, Willard HF, Davies KE. A novel gene, DXS8237E, lies within 20 kb upstream of UBE1 in Xp11.23 and has a different X inactivation status. Genomics. 31: 135-8. PMID 8808293 DOI: 10.1006/Geno.1996.0022 |
0.323 |
|
| 1996 |
Rowe PS, Goulding JN, Francis F, Oudet C, Econs MJ, Hanauer A, Lehrach H, Read AP, Mountford RC, Summerfield T, Weissenbach J, Fraser W, Drezner MK, Davies KE, O'Riordan JL. The gene for X-linked hypophosphataemic rickets maps to a 200-300kb region in Xp22.1, and is located on a single YAC containing a putative vitamin D response element (VDRE). Human Genetics. 97: 345-52. PMID 8786079 DOI: 10.1007/Bf02185769 |
0.318 |
|
| 1996 |
Nawrotzki R, Blake DJ, Davies KE. The genetic basis of neuromuscular disorders. Trends in Genetics : Tig. 12: 294-8. PMID 8783938 DOI: 10.1016/0168-9525(96)10033-0 |
0.372 |
|
| 1996 |
Theodosiou AM, Rodrigues NR, Nesbit MA, Ambrose HJ, Paterson H, McLellan-Arnold E, Boyd Y, Leversha MA, Owen N, Blake DJ, Ashworth A, Davies KE. A member of the MAP kinase phosphatase gene family in mouse containing a complex trinucleotide repeat in the coding region. Human Molecular Genetics. 5: 675-84. PMID 8733137 DOI: 10.1093/Hmg/5.5.675 |
0.359 |
|
| 1996 |
Dennis CL, Tinsley JM, Deconinck AE, Davies KE. Molecular and functional analysis of the utrophin promoter. Nucleic Acids Research. 24: 1646-52. PMID 8649981 DOI: 10.1093/nar/24.9.1646 |
0.351 |
|
| 1996 |
Blake DJ, Nawrotzki R, Peters MF, Froehner SC, Davies KE. Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. The Journal of Biological Chemistry. 271: 7802-10. PMID 8631824 DOI: 10.1074/jbc.271.13.7802 |
0.344 |
|
| 1995 |
Schofield JN, Górecki DC, Blake DJ, Davies KE, Edwards YH. Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: A comparison with utrophin and the apo-dystrophins Developmental Dynamics. 204: 178-185. PMID 8589441 DOI: 10.1002/Aja.1002040208 |
0.329 |
|
| 1995 |
Nguyen TM, Helliwell TR, Simmons C, Winder SJ, Kendrick-Jones J, Davies KE, Morris GE. Full-length and short forms of utrophin, the dystrophin-related protein. Febs Letters. 358: 262-6. PMID 7843413 DOI: 10.1016/0014-5793(94)01441-3 |
0.308 |
|
| 1995 |
Blake DJ, Tinsley JM, Davies KE, Knight AE, Winder SJ, Kendrick-Jones J. Coiled-coil regions in the carboxy-terminal domains of dystrophin and related proteins: potentials for protein-protein interactions. Trends in Biochemical Sciences. 20: 133-5. PMID 7770909 DOI: 10.1016/S0968-0004(00)88986-0 |
0.387 |
|
| 1995 |
Daniels RJ, Campbell L, Rodrigues NR, Francis MJ, Morrison KE, McLean M, MacKenzie A, Ignatius J, Dubowitz V, Davies KE. Genomic rearrangements in childhood spinal muscular atrophy: linkage disequilibrium with a null allele. Journal of Medical Genetics. 32: 93-6. PMID 7760328 DOI: 10.1136/Jmg.32.2.93 |
0.32 |
|
| 1995 |
Black GC, Coleman MP, Chen ZY, Nemeth AH, Davies KE, Craig IW. A bidirectional YAC walk from the Norrie disease (NDP) locus. Genomics. 25: 644-9. PMID 7759098 DOI: 10.1016/0888-7543(95)80006-8 |
0.332 |
|
| 1995 |
Rocques PJ, Clark J, Ball S, Crew J, Gill S, Christodoulou Z, Borts RH, Louis EJ, Davies KE, Cooper CS. The human SB1.8 gene (DXS423E) encodes a putative chromosome segregation protein conserved in lower eukaryotes and prokaryotes. Human Molecular Genetics. 4: 243-9. PMID 7757074 DOI: 10.1093/HMG/4.2.243 |
0.719 |
|
| 1995 |
Blake DJ, Schofield JN, Zuellig RA, Górecki DC, Phelps SR, Barnard EA, Edwards YH, Davies KE. G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. Proceedings of the National Academy of Sciences of the United States of America. 92: 3697-701. PMID 7731967 DOI: 10.1073/Pnas.92.9.3697 |
0.324 |
|
| 1995 |
Dubowitz V, Daniels RJ, Davies KE. Olivopontocerebellar hypoplasia with anterior horn cell involvement (SMA) does not localize to chromosome 5q. Neuromuscular Disorders : Nmd. 5: 25-9. PMID 7719137 DOI: 10.1016/0960-8966(94)00043-9 |
0.324 |
|
| 1995 |
Rodrigues NR, Owen N, Talbot K, Ignatius J, Dubowitz V, Davies KE. Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Human Molecular Genetics. 4: 631-4. PMID 7633412 DOI: 10.1093/Hmg/4.4.631 |
0.739 |
|
| 1995 |
Jasmin BJ, Alameddine H, Lunde JA, Stetzkowski-Marden F, Collin H, Tinsley JM, Davies KE, Tomé FM, Parry DJ, Cartaud J. Expression of utrophin and its mRNA in denervated mdx mouse muscle. Febs Letters. 374: 393-8. PMID 7589578 DOI: 10.1016/0014-5793(95)01131-W |
0.303 |
|
| 1995 |
Francis MJ, Nesbit MA, Theodosiou AM, Rodrigues NR, Campbell L, Christodoulou Z, Qureshi SJ, Porteous DJ, Brookes AJ, Davies KE. Mapping of retrotransposon sequences in the unstable region surrounding the spinal muscular atrophy locus in 5q13. Genomics. 27: 366-9. PMID 7558009 DOI: 10.1006/geno.1995.1059 |
0.36 |
|
| 1995 |
Francis F, Hennig S, Korn B, Reinhardt R, de Jong P, Poustka A, Lehrach H, Rowe PSN, Goulding JN, Summerfield T, Mountford R, Read AP, Popowska E, Pronicka E, Davies KE, et al. A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets Nature Genetics. 11: 130-136. PMID 7550339 DOI: 10.1038/Ng1095-130 |
0.368 |
|
| 1994 |
Blake DJ, Tinsley JM, Davies KE. The emerging family of dystrophin-related proteins. Trends in Cell Biology. 4: 19-23. PMID 14731825 DOI: 10.1016/0962-8924(94)90034-5 |
0.348 |
|
| 1994 |
Rowe PS, Goulding J, Read A, Lehrach H, Francis F, Hanauer A, Oudet C, Biancalana V, Kooh SW, Davies KE. Refining the genetic map for the region flanking the X-linked hypophosphataemic rickets locus (Xp22.1-22.2). Human Genetics. 93: 291-4. PMID 8125480 DOI: 10.1007/Bf00212025 |
0.313 |
|
| 1994 |
Coleman MP, Németh AH, Campbell L, Raut CP, Weissenbach J, Davies KE. A 1.8-Mb YAC contig in Xp11.23: identification of CpG islands and physical mapping of CA repeats in a region of high gene density. Genomics. 21: 337-43. PMID 8088827 DOI: 10.1006/geno.1994.1274 |
0.318 |
|
| 1994 |
Mérette C, Brzustowicz LM, Daniels RJ, Davies KE, Gilliam TC, Melki J, Munnich A, Pericak-Vance MA, Siddique T, Voosen B. An investigation of genetic heterogeneity and linkage disequilibrium in 161 families with spinal muscular atrophy. Genomics. 21: 27-33. PMID 8088801 DOI: 10.1006/Geno.1994.1220 |
0.305 |
|
| 1994 |
Tinsley JM, Blake DJ, Zuellig RA, Davies KE. Increasing complexity of the dystrophin-associated protein complex. Proceedings of the National Academy of Sciences of the United States of America. 91: 8307-13. PMID 8078878 DOI: 10.1073/Pnas.91.18.8307 |
0.352 |
|
| 1994 |
Schofield JN, Blake DJ, Simmons C, Morris GE, Tinsley JM, Davies KE, Edwards YH. Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines. Human Molecular Genetics. 3: 1309-16. PMID 7987307 DOI: 10.1093/Hmg/3.8.1309 |
0.318 |
|
| 1994 |
Komatsu H, Takeuchi Y, Miyanomae Y, Yoshioka H, Daniels R, Davies KE, Sawada T. Spinal muscular atrophy in trizygotic triplets. Acta Paediatrica Japonica; Overseas Edition. 36: 522-6. PMID 7825456 DOI: 10.1111/J.1442-200X.1994.Tb03239.X |
0.34 |
|
| 1993 |
Tinsley JM, Blake DJ, Davies KE. Apo-dystrophin-3: a 2.2kb transcript from the DMD locus encoding the dystrophin glycoprotein binding site. Human Molecular Genetics. 2: 521-4. PMID 8518789 DOI: 10.1093/hmg/2.5.521 |
0.319 |
|
| 1993 |
Passos-Bueno MR, Byth BC, Rosenberg S, Takata RI, Bakker E, Beggs AH, Pavanello RC, Vainzof M, Davies KE, Zatz M. Severe nonspecific X-linked mental retardation caused by a proximally Xp located gene: intragenic heterogeneity or a new form of X-linked mental retardation? American Journal of Medical Genetics. 46: 172-5. PMID 8484404 DOI: 10.1002/Ajmg.1320460214 |
0.338 |
|
| 1993 |
Karpati G, Carpenter S, Morris GE, Davies KE, Guerin C, Holland P. Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. Journal of Neuropathology and Experimental Neurology. 52: 119-28. PMID 8440993 DOI: 10.1097/00005072-199303000-00004 |
0.324 |
|
| 1993 |
Hirst MC, Knight SJ, Christodoulou Z, Grewal PK, Fryns JP, Davies KE. Origins of the fragile X syndrome mutation. Journal of Medical Genetics. 30: 647-50. PMID 8411050 DOI: 10.1136/Jmg.30.8.647 |
0.348 |
|
| 1993 |
Thompson TG, Morrison KE, Kleyn P, Bengtsson U, Gilliam TC, Davies KE, Wasmuth JJ, McPherson JD. High resolution physical map of the region surrounding the spinal muscular atrophy gene. Human Molecular Genetics. 2: 1169-76. PMID 8401498 DOI: 10.1093/Hmg/2.8.1169 |
0.332 |
|
| 1993 |
Tinsley JM, Blake DJ, Pearce M, Knight AE, Kendrick-Jones J, Davies KE. Dystrophin and related proteins. Current Opinion in Genetics & Development. 3: 484-90. PMID 8353425 DOI: 10.1016/0959-437X(93)90124-8 |
0.334 |
|
| 1993 |
Love DR, Byth BC, Tinsley JM, Blake DJ, Davies KE. Dystrophin and dystrophin-related proteins: a review of protein and RNA studies. Neuromuscular Disorders : Nmd. 3: 5-21. PMID 8329888 DOI: 10.1016/0960-8966(93)90037-K |
0.358 |
|
| 1993 |
Pearce M, Blake DJ, Tinsley JM, Byth BC, Campbell L, Monaco AP, Davies KE. The utrophin and dystrophin genes share similarities in genomic structure. Human Molecular Genetics. 2: 1765-72. PMID 8281135 DOI: 10.1093/Hmg/2.11.1765 |
0.349 |
|
| 1993 |
Tinsley JM, Davies KE. Utrophin: a potential replacement for dystrophin? Neuromuscular Disorders : Nmd. 3: 537-9. PMID 8186707 DOI: 10.1016/0960-8966(93)90111-V |
0.351 |
|
| 1993 |
Schofield J, Houzelstein D, Davies K, Buckingham M, Edwards YH. Expression of the dystrophin‐related protein (utrophin) gene during mouse embryogenesis Developmental Dynamics. 198: 254-264. PMID 8130373 DOI: 10.1002/Aja.1001980403 |
0.345 |
|
| 1993 |
Glass IA, Good P, Coleman MP, Fullwood P, Giles MG, Lindsay S, Nemeth AH, Davies KE, Willshaw HA, Fielder A. Genetic mapping of a cone and rod dysfunction (Aland Island eye disease) to the proximal short arm of the human X chromosome. Journal of Medical Genetics. 30: 1044-50. PMID 7907666 DOI: 10.1136/Jmg.30.12.1044 |
0.328 |
|
| 1992 |
Lindsay S, Thiselton DL, Bateman JB, Ngo JT, Sparkes RS, Coleman M, Davies KE, Bhattacharya SS. Localisation of the gene for Norrie disease to between DXS7 and DXS426 on Xp. Human Genetics. 88: 349-50. PMID 1733838 DOI: 10.1007/Bf00197273 |
0.316 |
|
| 1992 |
Dunckley MG, Love DR, Davies KE, Walsh FS, Morris GE, Dickson G. Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro. Febs Letters. 296: 128-34. PMID 1733767 DOI: 10.1016/0014-5793(92)80363-L |
0.383 |
|
| 1992 |
Hirst MC, Knight SM, Nakahori Y, Roche A, Davies KE. Molecular analysis of the fragile X syndrome. Journal of Inherited Metabolic Disease. 15: 532-8. PMID 1528014 DOI: 10.1007/BF01799612 |
0.335 |
|
| 1992 |
Helliwell TR, Man NT, Morris GE, Davies KE. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies. Neuromuscular Disorders : Nmd. 2: 177-84. PMID 1483043 DOI: 10.1016/0960-8966(92)90004-P |
0.309 |
|
| 1992 |
Byth BC, Love DR, Murray JC, Davies KE. Localization of two new DNA markers on the linkage map of human chromosome 6q. Cytogenetics and Cell Genetics. 60: 216-8. PMID 1354595 DOI: 10.1159/000133342 |
0.315 |
|
| 1992 |
Wöhrle D, Hirst MC, Kennerknecht I, Davies KE, Steinbach P. Genotype mosaicism in fragile X fetal tissues. Human Genetics. 89: 114-6. PMID 1349561 DOI: 10.1007/BF00207057 |
0.33 |
|
| 1992 |
Hirst MC, Knight SJ, Bell MV, Super M, Davies KE. The fragile X syndrome. Clinical Science (London, England : 1979). 83: 255-64. PMID 1327643 DOI: 10.1042/Cs0830255 |
0.312 |
|
| 1992 |
Chen ZY, Sims KB, Coleman M, Donnai D, Monaco A, Breakefield XO, Davies KE, Craig IW. Characterization of a YAC containing part or all of the Norrie disease locus. Human Molecular Genetics. 1: 161-4. PMID 1303171 DOI: 10.1093/Hmg/1.3.161 |
0.314 |
|
| 1992 |
Walker AP, Chelly J, Love DR, Brush YI, Récan D, Chaussain JL, Oley CA, Connor JM, Yates J, Price DA, Super M, Bottani A, Steinman B, Kaplan JC, Davies KE, et al. A YAC contig in Xp21 containing the adrenal hypoplasia congenita and glycerol kinase deficiency genes Human Molecular Genetics. 1: 579-585. PMID 1301166 DOI: 10.1093/Hmg/1.8.579 |
0.322 |
|
| 1992 |
Blake DJ, Love DR, Tinsley J, Morris GE, Turley H, Gatter K, Dickson G, Edwards YH, Davies KE. Characterization of a 4.8kb transcript from the Duchenne muscular dystrophy locus expressed in Schwannoma cells. Human Molecular Genetics. 1: 103-9. PMID 1301145 DOI: 10.1093/hmg/1.2.103 |
0.346 |
|
| 1992 |
Wells DJ, Wells KE, Walsh FS, Davies KE, Goldspink G, Love DR, Chan-Thomas P, Dunckley MG, Piper T, Dickson G. Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice. Human Molecular Genetics. 1: 35-40. PMID 1301134 DOI: 10.1093/Hmg/1.1.35 |
0.398 |
|
| 1991 |
Love DR, England SB, Speer A, Marsden RF, Bloomfield JF, Roche AL, Cross GS, Mountford RC, Smith TJ, Davies KE. Sequences of junction fragments in the deletion-prone region of the dystrophin gene. Genomics. 10: 57-67. PMID 2045110 DOI: 10.1016/0888-7543(91)90484-V |
0.358 |
|
| 1991 |
Love DR, Morris GE, Ellis JM, Fairbrother U, Marsden RF, Bloomfield JF, Edwards YH, Slater CP, Parry DJ, Davies KE. Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse. Proceedings of the National Academy of Sciences of the United States of America. 88: 3243-7. PMID 2014247 DOI: 10.1073/Pnas.88.8.3243 |
0.38 |
|
| 1991 |
Dickson G, Love DR, Davies KE, Wells KE, Piper TA, Walsh FS. Human dystrophin gene transfer: production and expression of a functional recombinant DNA-based gene. Human Genetics. 88: 53-8. PMID 1959926 DOI: 10.1007/Bf00204929 |
0.393 |
|
| 1991 |
Nakahori Y, Knight SJL, Holland J, Schwartz C, Roche A, Tarleton J, Wong S, Flint TJ, Froster-Iskenius U, Bentley D, Davies KE, Hirst MC. Molecular heterogeneity of the fragile X syndrome. Nucleic Acids Research. 19: 4355-4359. PMID 1886762 DOI: 10.1093/Nar/19.16.4355 |
0.317 |
|
| 1991 |
Acsadi G, Dickson G, Love DR, Jani A, Walsh FS, Gurusinghe A, Wolff JA, Davies KE. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature. 352: 815-8. PMID 1881437 DOI: 10.1038/352815A0 |
0.381 |
|
| 1991 |
Davies KE, Thomas NH, Daniels RJ, Dubowitz V. Molecular studies of spinal muscular atrophy. Neuromuscular Disorders : Nmd. 1: 83-5. PMID 1822785 DOI: 10.1016/0960-8966(91)90053-U |
0.41 |
|
| 1991 |
Coleman MP, Murray JC, Willard HF, Nolan KF, Reid KB, Blake DJ, Lindsay S, Bhattacharya SS, Wright A, Davies KE. Genetic and physical mapping around the properdin P gene. Genomics. 11: 991-6. PMID 1783405 DOI: 10.1016/0888-7543(91)90024-9 |
0.323 |
|
| 1991 |
Love DR, Flint TJ, Genet SA, Middleton-Price HR, Davies KE. Becker muscular dystrophy patient with a large intragenic dystrophin deletion: implications for functional minigenes and gene therapy. Journal of Medical Genetics. 28: 860-4. PMID 1757963 DOI: 10.1136/Jmg.28.12.860 |
0.394 |
|
| 1991 |
Nguyen TM, Ellis JM, Love DR, Davies KE, Gatter KC, Dickson G, Morris GE. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. The Journal of Cell Biology. 115: 1695-700. PMID 1757469 DOI: 10.1083/Jcb.115.6.1695 |
0.328 |
|
| 1990 |
England SB, Nicholson LVB, Johnson MA, Forrest SM, Love DR, Zubrzycka-Gaarn EE, Bulman DE, Harris JB, Davies KE. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin Nature. 343: 180-182. PMID 2404210 DOI: 10.1038/343180A0 |
0.407 |
|
| 1990 |
Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC, Daniels R, Davies KE, Leppert M, Ziter F, Wood D, Dubowitz V, Zerres K, Hausmanowa-Petrusewicz I, Ott J, Munsat TL, et al. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q1 1.2-13.3 Nature. 344: 540-541. PMID 2320125 DOI: 10.1038/344540A0 |
0.344 |
|
| 1990 |
Munsat TL, Skerry L, Korf B, Pober B, Schapira Y, Gascon GG, Al-Rajeh SM, Dubowitz V, Davies K, Brzustowicz LM, Penchaszadeh GK, Gilliam TC. Phenotypic heterogeneity of spinal muscular atrophy mapping to chromosome 5q11.2-13.3 (SMA 5q) Neurology. 40: 1831-1836. PMID 2247230 DOI: 10.1212/WNL.40.12.1831 |
0.336 |
|
| 1990 |
Love DR, Flint TJ, Marsden RF, Bloomfield JF, Daniels RJ, Forrest SM, Gabrielli O, Giorgi P, Novelli G, Davies KE. Characterization of deletions in the dystrophin gene giving mild phenotypes American Journal of Medical Genetics. 37: 136-142. PMID 2240031 DOI: 10.1002/ajmg.1320370132 |
0.389 |
|
| 1990 |
Buckle VJ, Guenet JL, Simon-Chazottes D, Love DR, Davies KE. Localisation of a dystrophin-related autosomal gene to 6q24 in man, and to mouse chromosome 10 in the region of the dystrophia muscularis (dy) locus Human Genetics. 85: 324-326. PMID 2203673 DOI: 10.1007/BF00206755 |
0.322 |
|
| 1990 |
Passos-Bueno MR, Rapaport D, Love D, Flint T, Bortolini ER, Zatz M, Davies KE. Screening of deletions in the dystrophin gene with the cDNA probes Cf23a, Cf56a, and Cf115. Journal of Medical Genetics. 27: 145-50. PMID 2182872 DOI: 10.1136/jmg.27.3.145 |
0.337 |
|
| 1990 |
Love DR, Bloomfield JF, Kenwrick SJ, Yates JRW, Davies KE. Physical mapping distal to the DMD locus Genomics. 8: 106-112. PMID 2081587 DOI: 10.1016/0888-7543(90)90231-I |
0.345 |
|
| 1990 |
Thakker RV, Davies KE, Read AP, Tippett P, Wooding C, Flint T, Woob S, Kruse TA, Whyte MP, O'Riordan JLH. Linkage analysis of two cloned DNA sequences, DXS197 and DXS207, in hypophosphatemic rickets families Genomics. 8: 189-193. PMID 1979046 DOI: 10.1016/0888-7543(90)90271-U |
0.307 |
|
| 1990 |
Thakker RV, Davies KE, Whyte MP, Wooding C, O'Riordan JLH. Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies Journal of Clinical Investigation. 86: 40-45. PMID 1973175 DOI: 10.1172/JCI114712 |
0.353 |
|
| 1989 |
Willard HF, Durfy SJ, Mahtani MM, Dorkins H, Davies KE, Williams BR. Regional localization of the TIMP gene on the human X chromosome. Extension of a conserved synteny and linkage group on proximal Xp. Human Genetics. 81: 234-8. PMID 2921031 DOI: 10.1007/Bf00278995 |
0.32 |
|
| 1989 |
Speer A, Spiegler AW, Hanke R, Grade K, Giertler U, Schieck J, Forrest S, Davies KE, Neumann R, Bollmann R. Possibilities and limitation of prenatal diagnosis and carrier determination for Duchenne and Becker muscular dystrophy using cDNA probes. Journal of Medical Genetics. 26: 1-5. PMID 2918522 DOI: 10.1136/jmg.26.1.1 |
0.304 |
|
| 1989 |
Love DR, Forrest SM, Smith TJ, England S, Flint T, Davies KE, Speer A. Molecular analysis of duschenne and becker muscular dystrophies British Medical Bulletin. 45: 659-680. PMID 2688822 DOI: 10.1093/OXFORDJOURNALS.BMB.A072351 |
0.385 |
|
| 1989 |
Thakker RV, Davies KE, O'Riordan JL. Gene mapping of mineral metabolic disorders. Journal of Inherited Metabolic Disease. 231-46. PMID 2681997 DOI: 10.1007/BF01799298 |
0.338 |
|
| 1989 |
Suthers GK, Callen DF, Hyland VJ, Kozman HM, Baker E, Eyre H, Harper PS, Roberts SH, Hors-Cayla MC, Davies KE, Bell MV, Sutherland GR. A new dna marker tightly linked to the fragile x locus (fraxa) Science. 246: 1298-1300. PMID 2573953 DOI: 10.1126/Science.2573953 |
0.315 |
|
| 1989 |
Love DR, Hill DF, Dickson G, Spurr NK, Byth BC, Marsden RF, Walsh FS, Edwards YH, Davies KE. An autosomal transcript in skeletal muscle with homology to dystrophin. Nature. 339: 55-8. PMID 2541343 DOI: 10.1038/339055A0 |
0.336 |
|
| 1988 |
Forrest SM, Cross GS, Flint T, Speer A, Robson KJH, Davies KE. Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies Genomics. 2: 109-114. PMID 3410474 DOI: 10.1016/0888-7543(88)90091-2 |
0.355 |
|
| 1988 |
Kenwrick SJ, Smith TJ, England S, Collins F, Davies KE. Localisation of the endpoints of deletions in the 5′ region of the duchenne gene using a sequence isolated by chromosome jumping Nucleic Acids Research. 16: 1305-1317. PMID 3347492 DOI: 10.1093/Nar/16.4.1305 |
0.336 |
|
| 1988 |
Davies KE, Kenwrick SJ, Patterson MN, Smith TJ, Forrest SM, Dorkins HR, Cross GS, England SB. Molecular analysis of muscular dystrophy. Journal of Muscle Research and Cell Motility. 9: 1-8. PMID 3292577 DOI: 10.1007/BF01682143 |
0.336 |
|
| 1988 |
Cavanna JS, Coulton G, Morgan JE, Brockdorff N, Forrest SM, Davies KE, Brown SD. Molecular and genetic mapping of the mouse mdx locus. Genomics. 3: 337-41. PMID 3243547 DOI: 10.1016/0888-7543(88)90124-3 |
0.37 |
|
| 1988 |
Read AP, Mountford RC, Forrest SM, Kenwrick SJ, Davies KE, Harris R. Patterns of exon deletions in Duchenne and Becker muscular dystrophy Human Genetics. 80: 152-156. PMID 3169738 DOI: 10.1007/BF00702859 |
0.335 |
|
| 1988 |
Davies KE, Smith TJ, Bundey S, Read AP, Flint T, Bell M, Speer A. Mild and severe muscular dystrophy associated with deletions in Xp21 of the human X chromosome Journal of Medical Genetics. 25: 9-13. PMID 3162536 DOI: 10.1136/jmg.25.1.9 |
0.371 |
|
| 1988 |
Davies KE, Patterson MN, Kenwrick SJ, Bell MV, Sloan HR, Westman JA, Elsas LJ, Mahan J. Fine mapping of glycerol kinase deficiency and congenital adrenal hypoplasia within Xp21 on the short arm of the human X chromosome. American Journal of Medical Genetics. 29: 557-64. PMID 2837087 DOI: 10.1002/AJMG.1320290313 |
0.313 |
|
| 1987 |
Davies KE, Gusella JF, Tsui LC, Williamson R, Page DC, Ferguson-Smith MA. Valuable libraries. Nature. 326: 124. PMID 3821885 DOI: 10.1038/326124e0 |
0.318 |
|
| 1987 |
Smith TJ, Forrest SM, Cross GS, Davies KE. Duchenne and becker muscular dystrophy mutations: Analysis using 2.6 kb of muscle cDNA from the 5′ end of the gene Nucleic Acids Research. 15: 9761-9769. PMID 3697082 DOI: 10.1093/nar/15.23.9761 |
0.37 |
|
| 1987 |
Davies KE, Robson KJ. Molecular analysis of human monogenic diseases Bioessays. 6: 247-253. PMID 3619885 DOI: 10.1002/Bies.950060602 |
0.399 |
|
| 1987 |
Reeders ST, Breuning MH, Ryynanen MA, Wright AF, Davies KE, King AW, Watson ML, Weatherall DJ. A study of genetic linkage heterogeneity in adult polycystic kidney disease. Human Genetics. 76: 348-51. PMID 3610154 DOI: 10.1007/BF00272443 |
0.317 |
|
| 1987 |
Brockdorff N, Cross GS, Cavanna JS, Fisher EM, Lyon MF, Davies KE, Brown SD. The mapping of a cDNA from the human X-linked Duchenne muscular dystrophy gene to the mouse X chromosome. Nature. 328: 166-8. PMID 3600793 DOI: 10.1038/328166A0 |
0.37 |
|
| 1987 |
Smith TJ, Wilson L, Kenwrick SJ, Forrest SM, Speer A, Coutelle C, Davies KE. Isolation of a conserved sequence deleted in Duchenne muscular dystrophy patients. Nucleic Acids Research. 15: 2167-74. PMID 3562224 DOI: 10.1093/NAR/15.5.2167 |
0.303 |
|
| 1987 |
Davies KE, Forrest S, Smith T, Kenwrick S, Ball S, Dorkins H, Patterson M. Molecular analysis of human muscular dystrophies Muscle & Nerve. 10: 191-199. PMID 2882417 DOI: 10.1002/Mus.880100302 |
0.365 |
|
| 1987 |
Thakker RV, Read AP, Davies KE, Whyte MP, Weksberg R, Glorieux F, Davies M, Mountford RC, Harris R, King A, Kim GS, Fraser D, Kooh SW, O'Riordan JLH. Bridging markers defining the map position of X linked hypophosphataemic rickets Journal of Medical Genetics. 24: 756-760. PMID 2828625 DOI: 10.1136/jmg.24.12.756 |
0.311 |
|
| 1987 |
Forrest SM, Cross GS, Speer A, Gardner-Medwin D, Burn J, Davies KE. Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature. 329: 638-40. PMID 2821406 DOI: 10.1038/329638a0 |
0.369 |
|
| 1987 |
Robbins TP, Scambler PJ, Davies KE, Williamson R. An anonymous clone E9pl (D4S112) localised to 4q26-qter detects an Msp I RFLP. Nucleic Acids Research. 15: 8122. PMID 2444927 DOI: 10.1093/nar/15.19.8122 |
0.324 |
|
| 1987 |
Cross GS, Speer A, Rosenthal A, Forrest SM, Smith TJ, Edwards Y, Flint T, Hill D, Davies KE. Deletions of fetal and adult muscle cDNA in Duchenne and Becker muscular dystrophy patients. The Embo Journal. 6: 3277-3283. DOI: 10.1002/j.1460-2075.1987.tb02646.x |
0.322 |
|
| 1986 |
Fischbeck KH, Ionasescu V, Ritter AW, Ionasescu R, Davies K, Ball S, Bosch P, Burns T, Hausmanowa-Petrusewicz I, Borkowska J. Localization of the gene for X-linked spinal muscular atrophy. Neurology. 36: 1595-8. PMID 3466055 DOI: 10.1212/Wnl.36.12.1595 |
0.335 |
|
| 1986 |
Kenwrick S, Ionasescu V, Ionasescu G, Searby C, King A, Dubowitz M, Davies KE. Linkage studies of X-linked recessive spastic paraplegia using DNA probes. Human Genetics. 73: 264-6. PMID 3460961 DOI: 10.1007/BF00401241 |
0.303 |
|
| 1986 |
Farrall M, Scambler P, Klinger KW, Davies K, Worrall C, Williamson R, Wainwright B. Cystic fibrosis carrier detection using a linked gene probe. Journal of Medical Genetics. 23: 295-299. PMID 3018247 DOI: 10.1136/Jmg.23.4.295 |
0.3 |
|
| 1986 |
Schwartz M, Christensen E, Christensen NC, Skovby F, Davies KE, Old JM. Detection and exclusion of carriers of ornithine transcarbamylase deficiency by RFLP analysis. Clinical Genetics. 29: 449-52. PMID 3017613 DOI: 10.1111/j.1399-0004.1986.tb00520.x |
0.324 |
|
| 1986 |
Pembrey ME, Old JM, Leonard JV, Rodeck CH, Warren R, Davies KE. Prenatal diagnosis of ornithine carbamoyl transferase deficiency using a gene specific probe. Journal of Medical Genetics. 22: 462-5. PMID 3001312 DOI: 10.1136/jmg.22.6.462 |
0.327 |
|
| 1986 |
Davies KE, Williamson R. Towards a complete linkage map of the human X chromosome. Horizons in Biochemistry and Biophysics. 8: 1-50. PMID 2875929 |
0.402 |
|
| 1986 |
Dunger DB, Pembrey M, Pearson P, Whitfield A, Davies KE, Lake B, Williams D, Dillon MJD. Deletion on the X chromosome detected by direct DNA analysis in one of two unrelated boys with glycerol kinase deficiency, adrenal hypoplasia, and Duchenne muscular dystrophy. The Lancet. 327: 585-587. PMID 2869305 DOI: 10.1016/S0140-6736(86)92811-4 |
0.316 |
|
| 1986 |
Thakker RV, Davies KE, Read AP, Glorieux F, O'Riordan JLH. LOCALISATION OF THE X-LINKED HYPOPHOSPHATAEMIC RICKETS GENE Pediatric Research. 20: 1185-1185. DOI: 10.1203/00006450-198611000-00068 |
0.331 |
|
| 1986 |
Davies KE. The elusive muscular dystrophy gene. Fifth Muscular Dystrophy Group Workshop on the X chromosome and muscular dystrophies, April 1986 Journal of Medical Genetics. 23: 482-483. DOI: 10.1136/jmg.23.6.482 |
0.314 |
|
| 1986 |
Pembrey ME, Winter RM, Davies KE. Fragile X mental retardation: current controversies Trends in Neurosciences. 9: 58-62. DOI: 10.1016/0166-2236(86)90021-4 |
0.345 |
|
| 1985 |
Davies KE, Speer A, Herrmann F, Spiegler AW, McGlade S, Hofker MH, Briand P, Hanke R, Schwartz M, Steinbicker V. Human X chromosome markers and Duchenne muscular dystrophy. Nucleic Acids Research. 13: 3419-26. PMID 3859837 DOI: 10.1093/NAR/13.10.3419 |
0.335 |
|
| 1985 |
Donald JA, Wallis SC, Kessling A, Tippett P, Robson EB, Ball S, Davies KE, Scambler P, Berg K, Heiberg A. Linkage relationships of the gene for apolipoprotein CII with loci on chromosome 19. Human Genetics. 69: 39-43. PMID 3855405 DOI: 10.1007/Bf00295527 |
0.329 |
|
| 1985 |
Davies KE, Briand P, Ionasescu V, Ionasescu G, Williamson R, Brown C, Cavard C, Cathelineau L. Gene for OTC: characterisation and linkage to Duchenne muscular dystrophy. Nucleic Acids Research. 13: 155-65. PMID 3839070 DOI: 10.1093/Nar/13.1.155 |
0.475 |
|
| 1985 |
Ball SP, Kenwrick SJ, Davies KE. The molecular genetics of human monogenic diseases Biotechnology and Genetic Engineering Reviews. 3: 275-309. PMID 3004535 DOI: 10.1080/02648725.1985.10647816 |
0.324 |
|
| 1985 |
Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, Pearson PL, Weatherall DJ. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature. 317: 542-4. PMID 2995836 DOI: 10.1038/317542a0 |
0.317 |
|
| 1985 |
Davies KE, Mattei MG, Mattei JF, Veenema H, McGlade S, Harper K, Tommerup N, Nielsen KB, Mikkelsen M, Beighton P, Drayna D, White R, Pembrey ME. Linkage studies of X-linked mental retardation: high frequency of recombination in the telomeric region of the human X chromosome (fragile site/linkage/recombination/X chromosome). Human Genetics. 70: 249-255. PMID 2991115 DOI: 10.1007/Bf00273451 |
0.31 |
|
| 1985 |
Ingle C, Williamson R, de la Chapelle A, Herva RR, Haapala K, Bates G, Willard HF, Pearson P, Davies KE. Mapping DNA sequences in a human X-chromosome deletion which extends across the region of the Duchenne muscular dystrophy mutation. American Journal of Human Genetics. 37: 451-62. PMID 2988331 |
0.397 |
|
| 1985 |
Scambler P, Robbins T, Gilliam C, Boylston A, Tippett P, Williamson R, Davies KE. Linkage studies between polymorphic markers on chromosome 4 and cystic fibrosis. Human Genetics. 69: 250-4. PMID 2984105 DOI: 10.1007/Bf00293035 |
0.478 |
|
| 1985 |
Bakker E, Hofker MH, Goor N, Mandel JL, Wrogemann K, Davies KE, Kunkel LM, Willard HF, Fenton WA, Sandkuyl L. Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet (London, England). 1: 655-8. PMID 2858615 DOI: 10.1016/S0140-6736(85)91325-X |
0.305 |
|
| 1985 |
Old JM, Briand PL, Purvis-Smith S, Howard NJ, Wilcken B, Hammond J, Pearson P, Cathelineau L, Williamson R, Davies KE. Prenatal exclusion of ornithine transcarbamylase deficiency by direct gene analysis. Lancet (London, England). 1: 73-5. PMID 2857026 DOI: 10.1016/S0140-6736(85)91966-X |
0.505 |
|
| 1984 |
Pembrey ME, Davies KE, Winter RM, Elles RG, Williamson R, Fazzone TA, Walker C. Clinical use of DNA markers linked to the gene for Duchenne muscular dystrophy. Archives of Disease in Childhood. 59: 208-16. PMID 6585184 DOI: 10.1136/Adc.59.3.208 |
0.495 |
|
| 1984 |
Hartley DA, Davies KE, Drayna D, White RL, Williamson R. A cytological map of the human X chromosome--evidence for non-random recombination. Nucleic Acids Research. 12: 5277-85. PMID 6547776 DOI: 10.1093/nar/12.13.5277 |
0.465 |
|
| 1984 |
Williamson R, Davies KE, Donald J, Gilliam C, Wallis S, Humphries S. The implications of genetic variation in human pathology. Biochemical Society Symposium. 49: 183-8. PMID 6400491 |
0.422 |
|
| 1984 |
Drayna D, Davies K, Hartley D, Mandel JL, Camerino G, Williamson R, White R. Genetic mapping of the human X chromosome by using restriction fragment length polymorphisms. Proceedings of the National Academy of Sciences of the United States of America. 81: 2836-2839. PMID 6326147 DOI: 10.1073/Pnas.81.9.2836 |
0.468 |
|
| 1984 |
Wieacker P, Davies KE, Cooke HJ, Pearson PL, Williamson R, Bhattacharya S, Zimmer J, Ropers HH. Toward a complete linkage map of the human X chromosome: regional assignment of 16 cloned single-copy DNA sequences employing a panel of somatic cell hybrids. American Journal of Human Genetics. 36: 265-76. PMID 6324578 |
0.402 |
|
| 1984 |
Davies KE, Harper K, Bonthron D, Krumlauf R, Polkey A, Pembrey ME, Williamson R. Use of a chromosome 21 cloned DNA probe for the analysis of non-disjunction in Down syndrome. Human Genetics. 66: 54-6. PMID 6230306 DOI: 10.1007/Bf00275186 |
0.46 |
|
| 1984 |
Gilliam TC, Scambler P, Robbins T, Ingle C, Williamson R, Davies KE. The positions of three restriction fragment length polymorphisms on chromosome 4 relative to known genetic markers. Human Genetics. 68: 154-8. PMID 6094335 DOI: 10.1007/Bf00279306 |
0.45 |
|
| 1983 |
Wieacker P, Wienker TF, Dallapiccola B, Bender K, Davies KE, Ropers HH. Linkage relationships between Retinoschisis, Xg, and a cloned DNA sequence from the distal short arm of the X chromosome. Human Genetics. 64: 143-5. PMID 6885047 DOI: 10.1007/Bf00327111 |
0.309 |
|
| 1983 |
Harper PS, O'Brien T, Murray JM, Davies KE, Pearson P, Williamson R. The use of linked DNA polymorphisms for genotype prediction in families with Duchenne muscular dystrophy. Journal of Medical Genetics. 20: 252-4. PMID 6684693 DOI: 10.1136/Jmg.20.4.252 |
0.452 |
|
| 1983 |
O'Brien T, Harper PS, Davies KE, Murray JM, Sarfarazi M, Williamson R. Absence of genetic heterogeneity in Duchenne muscular dystrophy shown by a linkage study using two cloned DNA sequences. Journal of Medical Genetics. 20: 249-51. PMID 6684692 DOI: 10.1136/Jmg.20.4.249 |
0.469 |
|
| 1983 |
Davies KE, Jackson J, Williamson R, Harper PS, Ball S, Sarfarazi M, Meredith L, Fey G. Linkage analysis of myotonic dystrophy and sequences on chromosome 19 using a cloned complement 3 gene probe. Journal of Medical Genetics. 20: 259-63. PMID 6620325 DOI: 10.1136/Jmg.20.4.259 |
0.469 |
|
| 1983 |
Davies KE, Taylor P, Müller CR. Sex chromosome-specific DNA sequences Differentiation. 23. PMID 6444174 DOI: 10.1007/978-3-642-69150-8_8 |
0.327 |
|
| 1983 |
Sarfarazi M, Harper PS, Kingston HM, Murray JM, O'Brien T, Davies KE, Williamson R, Tippett P, Sanger R. Genetic linkage relationship between the Xg blood group system and two X chromosome DNA polymorphisms in families with Duchenne and Becker muscular dystrophy. Human Genetics. 65: 169-71. PMID 6317539 DOI: 10.1007/Bf00286656 |
0.458 |
|
| 1983 |
Davies KE, Pearson PL, Harper PS, Murray JM, O'Brien T, Sarfarazi M, Williamson R. Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Research. 11: 2303-12. PMID 6304647 DOI: 10.1093/Nar/11.8.2303 |
0.483 |
|
| 1983 |
Kingston HM, Harper PS, Pearson PL, Davies KE, Williamson R, Page D. Localisation of gene for Becker muscular dystrophy. Lancet (London, England). 2: 1200. PMID 6139558 DOI: 10.1016/S0140-6736(83)91252-7 |
0.486 |
|
| 1983 |
Davies KE, Harper PS, Williamson R. Cloned gene probes for carrier detection in muscular dystrophy. Lancet (London, England). 2: 108. PMID 6134944 DOI: 10.1016/S0140-6736(83)90095-8 |
0.47 |
|
| 1983 |
Davies KE, Gilliam TC, Williamson R. Cystic fibrosis is not caused by a defect in the gene coding for human complement C3. Molecular Biology & Medicine. 1: 185-90. PMID 6094950 |
0.421 |
|
| 1982 |
Murray JM, Davies KE, Harper PS, Meredith L, Mueller CR, Williamson R. Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature. 300: 69-71. PMID 6982420 DOI: 10.1038/300069A0 |
0.482 |
|
| 1982 |
Hill ME, Davies KE, Harper P, Williamson R. The Mendelian inheritance of a human X chromosome-specific DNA sequence polymorphism and its use in linkage studies of genetic disease. Human Genetics. 60: 222-6. PMID 6286461 DOI: 10.1007/Bf00303007 |
0.476 |
|
| 1981 |
Davies KE, Young BD, Elles RG, Hill ME, Williamson R. Cloning of a representative genomic library of the human X chromosome after sorting by flow cytometry. Nature. 293: 374-6. PMID 6456416 DOI: 10.1038/293374A0 |
0.464 |
|
| 1981 |
Hill MEE, Ellis RG, Davies KE, Williamson R. Cloning Of A Library Representative Of The Human X-Chromosome Biochemical Society Transactions. 9. DOI: 10.1042/Bst009130Pe |
0.441 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1987 |
Forrest SM, Smith TJ, Cross GS, Read AP, Thomas NS, Mountford RC, Harper PS, Geirsson RT, Davies KE. Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (London, England). 2: 1294-7. PMID 2890901 DOI: 10.1016/S0140-6736(87)91192-5 |
0.3 |
|
| 2003 |
Howman EV, Sullivan N, Poon EP, Britton JE, Hilton-Jones D, Davies KE. Syncoilin accumulation in two patients with desmin-related myopathy. Neuromuscular Disorders : Nmd. 13: 42-8. PMID 12467731 DOI: 10.1016/S0960-8966(02)00181-5 |
0.3 |
|
| 1983 |
Wieacker P, Davies KE, Mevorah B, Ropers HH. Linkage studies in a family with X-linked recessive ichthyosis employing a cloned DNA sequence from the distal short arm of the X chromosome Human Genetics. 63: 113-116. PMID 6301973 DOI: 10.1007/BF00291528 |
0.299 |
|
| 1993 |
Hirst MC, Barnicoat A, Flynn G, Wang Q, Daker M, Buckle VJ, Davies KE, Bobrow M. The identification of a third fragile site, FRAXF, in Xq27--q28 distal to both FRAXA and FRAXE. Human Molecular Genetics. 2: 197-200. PMID 8499907 DOI: 10.1093/Hmg/2.2.197 |
0.299 |
|
| 1992 |
Knight SJL, Hirst MC, Roche A, Christodoulou Z, Huson SM, Winter R, Fitchett M, McKinley MJ, Lindenbaum RH, Nakahori Y, Davies KE. Molecular studies of the fragile X syndrome. American Journal of Medical Genetics. 43: 217-223. PMID 1605194 DOI: 10.1002/Ajmg.1320430135 |
0.299 |
|
| 2018 |
Gordish-Dressman H, Willmann R, Pazze LD, Kreibich A, van Putten M, Heydemann A, Bogdanik L, Lutz C, Davies K, Demonbruen AR, Duan D, Elsey D, Fukada SI, Girgenrath M, Gonzalez JP, et al. "Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic First Workshop Report: Examining current findings and opportunities around the emerging D2.B10-Dmdmdx/J (D2/mdx) model in context of the classic C57BL/10ScSn-Dmdmdx/J (Bl10/mdx). Journal of Neuromuscular Diseases. PMID 30198876 DOI: 10.3233/Jnd-180324 |
0.298 |
|
| 1998 |
Loh NY, Ambrose HJ, Guay-Woodford LM, DasGupta S, Nawrotzki RA, Blake DJ, Davies KE. Genomic organization and refined mapping of the mouse beta-dystrobrevin gene. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 9: 857-62. PMID 9799833 DOI: 10.1007/S003359900883 |
0.298 |
|
| 2001 |
Newey SE, Howman EV, Ponting CP, Benson MA, Nawrotzki R, Loh NY, Davies KE, Blake DJ. Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle. The Journal of Biological Chemistry. 276: 6645-55. PMID 11053421 DOI: 10.1074/Jbc.M008305200 |
0.298 |
|
| 2019 |
Davies KE, Guiraud S. Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular Dystrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 27: 486-488. PMID 30765324 DOI: 10.1016/j.ymthe.2019.01.019 |
0.297 |
|
| 1985 |
Brown CS, Thomas NS, Sarfarazi M, Davies KE, Kunkel L, Pearson PL, Kingston HM, Shaw DJ, Harper PS. Genetic linkage relationships of seven DNA probes with Duchenne and Becker muscular dystrophy. Human Genetics. 71: 62-74. PMID 2993158 DOI: 10.1007/Bf00295671 |
0.297 |
|
| 1998 |
Deconinck N, Rafael JA, Beckers-Bleukx G, Kahn D, Deconinck AE, Davies KE, Gillis JM. Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse. Neuromuscular Disorders : Nmd. 8: 362-70. PMID 9713852 DOI: 10.1016/S0960-8966(98)00048-0 |
0.297 |
|
| 2002 |
Rybakova IN, Patel JR, Davies KE, Yurchenco PD, Ervasti JM. Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle. Molecular Biology of the Cell. 13: 1512-21. PMID 12006649 DOI: 10.1091/Mbc.01-09-0446 |
0.297 |
|
| 1995 |
Macpherson JN, Curtis G, Crolla JA, Dennis N, Migeon B, Grewal PK, Hirst MC, Davies KE, Jacobs PA. Unusual (CGG)n expansion and recombination in a family with fragile X and DiGeorge syndrome. Journal of Medical Genetics. 32: 236-9. PMID 7783179 DOI: 10.1136/Jmg.32.3.236 |
0.297 |
|
| 1992 |
Laval SH, Blair HJ, Hirst MC, Davies KE, Boyd Y. Mapping of FMR1, the gene implicated in fragile X-linked mental retardation, on the mouse X chromosome. Genomics. 12: 818-21. PMID 1572655 DOI: 10.1016/0888-7543(92)90315-J |
0.297 |
|
| 2011 |
Goyenvalle A, Davies KE. Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy. Skeletal Muscle. 1: 8. PMID 21798085 DOI: 10.1186/2044-5040-1-8 |
0.296 |
|
| 1996 |
Holden JJ, Julien-Inalsingh C, Chalifoux M, Wing M, Scott E, Fidler K, Swift I, Maidment B, Knight SJ, Davies KE, White BN. Trinucleotide repeat expansion in the FRAXE locus is not common among institutionalized individuals with non-specific developmental disabilities. American Journal of Medical Genetics. 64: 420-3. PMID 8844096 DOI: 10.1002/(Sici)1096-8628(19960809)64:2<420::Aid-Ajmg37>3.0.Co;2-F |
0.296 |
|
| 1991 |
Passos-Bueno MR, Terwilliger J, Ott J, Vainzof M, Love DR, Davies KE, Zatz M. Linkage analysis in families with autosomal recessive limb-girdle muscular dystrophy (LGMD) and 6q probes flanking the dystrophin-related sequence. American Journal of Medical Genetics. 38: 140-6. PMID 2012126 DOI: 10.1002/Ajmg.1320380130 |
0.296 |
|
| 2001 |
Newey SE, Gramolini AO, Wu J, Holzfeind P, Jasmin BJ, Davies KE, Blake DJ. A novel mechanism for modulating synaptic gene expression: differential localization of alpha-dystrobrevin transcripts in skeletal muscle. Molecular and Cellular Neurosciences. 17: 127-40. PMID 11161474 DOI: 10.1006/Mcne.2000.0918 |
0.295 |
|
| 1997 |
Abrams MT, Doheny KF, Mazzocco MM, Knight SJ, Baumgardner TL, Freund LS, Davies KE, Reiss AL. Cognitive, behavioral, and neuroanatomical assessment of two unrelated male children expressing FRAXE. American Journal of Medical Genetics. 74: 73-81. PMID 9034011 DOI: 10.1002/(SICI)1096-8628(19970221)74:1<73::AID-AJMG16>3.0.CO;2-O |
0.294 |
|
| 1995 |
Brown CJ, Miller AP, Carrel L, Rupert JL, Davies KE, Willard HF. The DXS423E gene in Xp11.21 escapes X chromosome inactivation. Human Molecular Genetics. 4: 251-5. PMID 7757075 DOI: 10.1093/Hmg/4.2.251 |
0.294 |
|
| 2007 |
Grounds MD, Davies KE. The allure of stem cell therapy for muscular dystrophy. Neuromuscular Disorders : Nmd. 17: 206-8. PMID 17306535 DOI: 10.1016/j.nmd.2007.01.007 |
0.294 |
|
| 2007 |
Davies KE, Grounds MD. Modified patient stem cells as prelude to autologous treatment of muscular dystrophy. Cell Stem Cell. 1: 595-6. PMID 18371397 DOI: 10.1016/j.stem.2007.11.003 |
0.294 |
|
| 1986 |
Davies KE. DNA studies of X-linked mental retardation associated with a fragile site at Xq27 American Journal of Medical Genetics. 23: 633-642. PMID 3513572 DOI: 10.1002/AJMG.1320230157 |
0.294 |
|
| 2010 |
Goyenvalle A, Babbs A, Powell D, Kole R, Fletcher S, Wilton S, Davies K. P26 Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping Neuromuscular Disorders. 20: S12. DOI: 10.1016/S0960-8966(10)70041-9 |
0.293 |
|
| 1988 |
Dickson G, Pizzey JA, Elsom VE, Love D, Davies KE, Walsh FS. Distinct dystrophin mRNA species are expressed in embryonic and adult mouse skeletal muscle. Febs Letters. 242: 47-52. PMID 3060377 DOI: 10.1016/0014-5793(88)80982-7 |
0.293 |
|
| 1996 |
Davies KE. Muscling in on gene therapy Molecular Medicine Today. 2. DOI: 10.1016/1357-4310(96)88776-4 |
0.292 |
|
| 1985 |
Pembrey ME, Winter RM, Davies KE. A premutation that generates a defect at crossing over explains the inheritance of fragile X mental retardation American Journal of Medical Genetics. 21: 709-717. PMID 4040705 DOI: 10.1002/AJMG.1320210413 |
0.292 |
|
| 2005 |
Sewry CA, Nowak KJ, Ehmsen JT, Davies KE. A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours. Neuromuscular Disorders : Nmd. 15: 779-85. PMID 16198105 DOI: 10.1016/j.nmd.2005.08.002 |
0.292 |
|
| 1998 |
Blake DJ, Nawrotzki R, Loh NY, Górecki DC, Davies KE. beta-dystrobrevin, a member of the dystrophin-related protein family. Proceedings of the National Academy of Sciences of the United States of America. 95: 241-6. PMID 9419360 DOI: 10.1073/pnas.95.1.241 |
0.292 |
|
| 1986 |
Reeders ST, Breuning MH, Corney G, Jeremiah SJ, Khan PM, Davies KE, Hopkinson DA, Pearson PL, Weatherall DJ. Two genetic markers closely linked to adult polycystic kidney disease on chromosome 16 British Medical Journal (Clinical Research Ed.). 292: 851-853. PMID 3008903 DOI: 10.1136/bmj.292.6524.851 |
0.292 |
|
| 1989 |
Winter RM, Davies KE, Bell MV, Huson SM, Patterson MN. MASA syndrome: further clinical delineation and chromosomal localisation Human Genetics. 82: 367-370. PMID 2737668 DOI: 10.1007/BF00273999 |
0.291 |
|
| 1986 |
Paulsen K, Forrest S, Scherer G, Ropers HH, Davies K. Regional localisation of X chromosome short arm probes. Human Genetics. 74: 155-159. PMID 3464558 DOI: 10.1007/Bf00282079 |
0.291 |
|
| 2003 |
Perkins KJ, Davies KE. Ets, Ap-1 and GATA factor families regulate the utrophin B promoter: potential regulatory mechanisms for endothelial-specific expression. Febs Letters. 538: 168-72. PMID 12633873 DOI: 10.1016/S0014-5793(03)00175-3 |
0.29 |
|
| 1997 |
Chakrabarti L, Davies KE. Fragile X syndrome. Current Opinion in Neurology. 10: 142-7. PMID 9146995 DOI: 10.1097/00019052-199704000-00012 |
0.289 |
|
| 1996 |
Pook MA, Thakrar R, Pottinger B, Harding B, Porteous D, van Heyningen V, Cowell J, Jones C, Povey S, Davies KE, Thakker RV. EagI and NotI linking clones from human chromosomes 11 and Xp. Human Genetics. 97: 742-9. PMID 8641690 DOI: 10.1007/Bf02346183 |
0.289 |
|
| 2008 |
Toms C, Jessup H, Thompson C, Baban D, Davies K, Powrie F. Gpr83 expression is not required for the maintenance of intestinal immune homeostasis and regulation of T-cell-dependent colitis Immunology. 125: 302-312. PMID 18479351 DOI: 10.1111/J.1365-2567.2008.02857.X |
0.289 |
|
| 1993 |
Gangadharan U, Maconochie MK, Davies KE, Brown SD. Isolation and characterization of a genomic clone from the murine utrophin locus. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 4: 608-11. PMID 8268660 DOI: 10.1007/Bf00361394 |
0.288 |
|
| 2016 |
Janghra N, Morgan JE, Sewry CA, Wilson FX, Davies KE, Muntoni F, Tinsley J. Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies. Plos One. 11: e0150818. PMID 26974331 DOI: 10.1371/journal.pone.0150818 |
0.288 |
|
| 1985 |
Davies KE. New hypervariable DNA markers for mapping human genetic disease Trends in Genetics. 1: 97. DOI: 10.1016/0168-9525(85)90038-1 |
0.287 |
|
| 1996 |
Matthews D, Fry L, Powles A, Weber J, McCarthy M, Fisher E, Davies K, Williamson R. Evidence that a locus for familial psoriasis maps to chromosome 4q Nature Genetics. 14: 231-233. PMID 8841203 DOI: 10.1038/Ng1096-231 |
0.287 |
|
| 2020 |
Davies KE. The Long Journey from Diagnosis to Therapy. Annual Review of Genomics and Human Genetics. PMID 32119789 DOI: 10.1146/annurev-genom-112019-083518 |
0.287 |
|
| 2015 |
Davies K. Interview with Professor Kay Davies Future Neurology. 10: 305-307. DOI: 10.2217/fnl.15.24 |
0.287 |
|
| 1987 |
Kenwrick S, Patterson M, Speer A, Fischbeck K, Davies K. Molecular analysis of the Duchenne muscular dystrophy region using pulsed field gel electrophoresis Cell. 48: 351-357. PMID 3026644 DOI: 10.1016/0092-8674(87)90438-7 |
0.287 |
|
| 2019 |
Tambuyzer E, Vandendriessche B, Austin CP, Brooks PJ, Larsson K, Miller Needleman KI, Valentine J, Davies K, Groft SC, Preti R, Oprea TI, Prunotto M. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews. Drug Discovery. PMID 31836861 DOI: 10.1038/s41573-019-0049-9 |
0.286 |
|
| 1985 |
Mattei MG, Baeteman MA, Heilig R, Oberlé I, Davies K, Mandel JL, Mattei JF. Localization by in situ hybridization of the coagulation factor IX gene and of two polymorphic DNA probes with respect to the fragile X site. Human Genetics. 69: 327-331. PMID 2985491 DOI: 10.1007/Bf00291650 |
0.286 |
|
| 1990 |
Gilliam TC, Brzustowicz LM, Castilla LH, Lehner T, Penchaszadeh GK, Daniels RJ, Byth BC, Knowles J, Hislop JE, Shapira Y, Dubowitz V, Munsat TL, Ott J, Davies KE. Genetic homogeneity between acute and chronic forms of spinal muscular atrophy Nature. 345: 823-825. PMID 1972783 DOI: 10.1038/345823A0 |
0.285 |
|
| 2002 |
Burton EA, Davies KE. Muscular dystrophy--reason for optimism? Cell. 108: 5-8. PMID 11792315 DOI: 10.1016/S0092-8674(01)00626-2 |
0.284 |
|
| 2009 |
Court FA, Hewitt JE, Davies K, Patton BL, Uncini A, Wrabetz L, Feltri ML. A laminin-2, dystroglycan, utrophin axis is required for compartmentalization and elongation of myelin segments Journal of Neuroscience. 29: 3908-3919. PMID 19321787 DOI: 10.1523/Jneurosci.5672-08.2009 |
0.284 |
|
| 2006 |
Martin-Rendon E, Hale SJM, Ryan D, Baban D, Forde SP, Davies K, Watt SM. SI10 Effects of Hypoxia on the Proliferation and Differentiation Potential of Human Cord Blood- and Bone Marrow-Derived Stem/Progenitor Cells Transfusion Medicine. 16: 7-8. DOI: 10.1111/j.1365-3148.2006.00693_15.x |
0.283 |
|
| 1993 |
Németh AH, Hunter N, Coleman MP, Borts RH, Louis EJ, Davies KE. Rescue of a single yeast artificial chromosome from a cotransformation event utilizing segregation at meiosis. Genetic Analysis, Techniques and Applications. 10: 123-7. PMID 8043304 DOI: 10.1016/1050-3862(93)90007-6 |
0.282 |
|
| 2006 |
Yokota T, Lu QL, Morgan JE, Davies KE, Fisher R, Takeda S, Partridge TA. Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. Journal of Cell Science. 119: 2679-87. PMID 16757519 DOI: 10.1242/jcs.03000 |
0.282 |
|
| 2012 |
Stuckey DJ, Carr CA, Camelliti P, Tyler DJ, Davies KE, Clarke K. In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy. Plos One. 7: e28569. PMID 22235247 DOI: 10.1371/journal.pone.0028569 |
0.282 |
|
| 1987 |
Wainwright B, Lench N, Davies K, Scambler P, Kruyer H, Williamson R, Jahnsen T, Farrall M. A human regulatory subunit of type II cAMP-dependent protein kinase localized by its linkage relationship to several cloned chromosome 7q markers. Cytogenetic and Genome Research. 45: 237-239. PMID 3691190 DOI: 10.1159/000132461 |
0.282 |
|
| 1984 |
Harper K, Winter RM, Pembrey ME, Hartley D, Davies KE, Tuddenham EG. A clinically useful DNA probe closely linked to haemophilia A. Lancet (London, England). 2: 6-8. PMID 6145983 DOI: 10.1016/S0140-6736(84)91995-0 |
0.282 |
|
| 1986 |
Davies KE. An up-to-date human gene map Trends in Genetics. 2: 253. DOI: 10.1016/0168-9525(86)90253-2 |
0.281 |
|
| 2007 |
Martin-Rendon E, Hale SJ, Ryan D, Baban D, Forde SP, Roubelakis M, Sweeney D, Moukayed M, Harris AL, Davies K, Watt SM. Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells (Dayton, Ohio). 25: 1003-12. PMID 17185612 DOI: 10.1634/stemcells.2006-0398 |
0.281 |
|
| 2005 |
Wilding JR, Schneider JE, Sang AE, Davies KE, Neubauer S, Clarke K. Dystrophin- and MLP-deficient mouse hearts: marked differences in morphology and function, but similar accumulation of cytoskeletal proteins. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 79-81. PMID 15494447 DOI: 10.1096/fj.04-1731fje |
0.281 |
|
| 1993 |
Rowe PS, Goulding J, Read A, Mountford R, Hanauer A, Oudet C, Whyte MP, Meier-Ewert S, Lehrach H, Davies KE. New markers for linkage analysis of X-linked hypophosphataemic rickets. Human Genetics. 91: 571-5. PMID 8101831 DOI: 10.1007/BF00205082 |
0.28 |
|
| 1986 |
Reeders ST, Gal A, Propping P, Waldherr R, Davies KE, Zerres K, Hogenkamp T, Schmidt W, Dolata MM, Weatherall DJ. Prenatal Diagnosis Of Autosomal Dominant Polycystic Kidney Disease With A Dna Probe The Lancet. 328: 6-8. PMID 2873352 DOI: 10.1016/S0140-6736(86)92557-2 |
0.28 |
|
| 1983 |
Müller CR, Davies KE, Cremer C, Rappold G, Gray JW, Ropers HH. Cloning of genomic sequences from the human Y chromosome after purification by dual beam flow sorting. Human Genetics. 64: 110-5. PMID 6885043 DOI: 10.1007/BF00327104 |
0.28 |
|
| 1991 |
Rowe P, Benham F, Read A, Thakker R, Kruse T, Camarino G, Davies KE, O'Riordan J. 5. Chromosomal localisation of DNA probes for the hypophosphataemic rickets gene Bone. 12: 288-288. DOI: 10.1016/8756-3282(91)90082-T |
0.28 |
|
| 1986 |
Lindsay S, Monk M, Holliday R, Huschtscha L, Davies KE, Riggs AD, Flavell RA. Differences in methylation on the active and inactive human X chromosomes. Annals of Human Genetics. 49: 115-27. PMID 3000273 DOI: 10.1111/J.1469-1809.1985.Tb01683.X |
0.28 |
|
| 1995 |
Slaney SF, Wilkie AO, Hirst MC, Charlton R, McKinley M, Pointon J, Christodoulou Z, Huson SM, Davies KE. DNA testing for fragile X syndrome in schools for learning difficulties. Archives of Disease in Childhood. 72: 33-7. PMID 7717734 DOI: 10.1136/Adc.72.1.33 |
0.28 |
|
| 2013 |
Hir ML, Goyenvalle A, Peccate C, Précigout G, Davies KE, Voit T, Garcia L, Lorain S. P.20.8 AAV genome loss from dystrophic mouse muscles during AAV-U7snRNA-mediated exon skipping therapy Neuromuscular Disorders. 23: 841-841. DOI: 10.1016/J.Nmd.2013.06.698 |
0.279 |
|
| 1985 |
Dorkins HR, Davies KE. Recombinant DNA technology in the clinical sciences Trends in Biotechnology. 3: 195-199. DOI: 10.1016/0167-7799(85)90045-9 |
0.279 |
|
| 1990 |
Man Nt, Cartwright AJ, Morris GE, Love DR, Bloomfield JF, Davies KE. Monoclonal antibodies against defined regions of the muscular dystrophy protein, dystrophin Febs Letters. 262: 237-240. PMID 1692289 DOI: 10.1016/0014-5793(90)80199-S |
0.279 |
|
| 2003 |
Vargas JD, Herpers B, McKie AT, Gledhill S, McDonnell J, van den Heuvel M, Davies KE, Ponting CP. Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases. Biochimica Et Biophysica Acta. 1651: 116-23. PMID 14499595 DOI: 10.1016/S1570-9639(03)00242-5 |
0.278 |
|
| 2013 |
Le Hir M, Goyenvalle A, Peccate C, Précigout G, Davies KE, Voit T, Garcia L, Lorain S. AAV genome loss from dystrophic mouse muscles during AAV-U7 snRNA-mediated exon-skipping therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1551-8. PMID 23752313 DOI: 10.1038/mt.2013.121 |
0.278 |
|
| 1998 |
Goudemant JF, Deconinck N, Tinsley JM, Demeure R, Robert A, Davies KE, Gillis JM. Expression of truncated utrophin improves pH recovery in exercising muscles of dystrophic mdx mice: a 31P NMR study. Neuromuscular Disorders : Nmd. 8: 371-9. PMID 9713853 DOI: 10.1016/S0960-8966(98)00049-2 |
0.277 |
|
| 1986 |
Read AP, Thakker RV, Davies KE, Mountford RC, Brenton DP, Davies M, Glorieux F, Harris R, Hendy GN, King A, McGlade S, Peacock CJ, Smith R, O'Riordan JLH. Mapping of human X-linked hypophosphataemic rickets by multilocus linkage analysis Human Genetics. 73: 267-270. PMID 3015770 DOI: 10.1007/Bf00401242 |
0.275 |
|
| 1992 |
Nguyen TM, Le TT, Blake DJ, Davies KE, Morris GE. Utrophin, the autosomal homologue of dystrophin, is widely-expressed and membrane-associated in cultured cell lines. Febs Letters. 313: 19-22. PMID 1426262 DOI: 10.1016/0014-5793(92)81174-K |
0.275 |
|
| 1994 |
Ritchie RJ, Knight SJ, Hirst MC, Grewal PK, Bobrow M, Cross GS, Davies KE. The cloning of FRAXF: trinucleotide repeat expansion and methylation at a third fragile site in distal Xqter. Human Molecular Genetics. 3: 2115-21. PMID 7881407 DOI: 10.1093/Hmg/3.12.2115 |
0.275 |
|
| 1987 |
Waye JS, Durfy SJ, Pinkel D, Kenwrick S, Patterson M, Davies KE, Willard HF. Chromosome-specific alpha satellite DNA from human chromosome 1: hierarchical structure and genomic organization of a polymorphic domain spanning several hundred kilobase pairs of centromeric DNA. Genomics. 1: 43-51. PMID 2889661 DOI: 10.1016/0888-7543(87)90103-0 |
0.275 |
|
| 1987 |
Patterson M, Kenwrick S, Thibodeau S, Faulk K, Mattei MG, Mattei JF, Davies KE. Mapping of DNA markers close to the fragile site on the human X chromosome at Xq27.3. Nucleic Acids Research. 15: 2639-51. PMID 2882476 DOI: 10.1093/NAR/15.6.2639 |
0.274 |
|
| 1994 |
Hirst MC, Grewal PK, Davies KE. Precursor arrays for triplet repeat expansion at the fragile X locus. Human Molecular Genetics. 3: 1553-60. PMID 7833910 DOI: 10.1093/hmg/3.9.1553 |
0.274 |
|
| 1992 |
Rowe PS, Read AP, Mountford R, Benham F, Kruse TA, Camerino G, Davies KE, O'Riordan JL. Three DNA markers for hypophosphataemic rickets. Human Genetics. 89: 539-42. PMID 1353055 DOI: 10.1007/BF00219180 |
0.274 |
|
| 2004 |
Ishikawa-Sakurai M, Yoshida M, Imamura M, Davies KE, Ozawa E. ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to beta-dystroglycan. Human Molecular Genetics. 13: 693-702. PMID 14962982 DOI: 10.1093/hmg/ddh087 |
0.274 |
|
| 1988 |
Ryder-Cook AS, Sicinski P, Thomas K, Davies KE, Worton RG, Barnard EA, Darlison MG, Barnard PJ. Localization of the mdx mutation within the mouse dystrophin gene. The Embo Journal. 7: 3017-21. PMID 2903046 |
0.274 |
|
| 2013 |
Davies K. The era of genomic medicine. Clinical Medicine (London, England). 13: 594-601. PMID 24298109 DOI: 10.7861/clinmedicine.13-6-594 |
0.274 |
|
| 1991 |
Delisi LE, Crow TJ, Davies KE, Terwilliger JD, Ott J, Ram R, Flint T, Boccio A. No genetic linkage detected for schizophrenia to Xq27-q28. The British Journal of Psychiatry : the Journal of Mental Science. 158: 630-4. PMID 1677599 DOI: 10.1192/Bjp.158.5.630 |
0.273 |
|
| 2002 |
Cole MA, Rafael JA, Taylor DJ, Lodi R, Davies KE, Styles P. A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin. Neuromuscular Disorders : Nmd. 12: 247-57. PMID 11801396 DOI: 10.1016/S0960-8966(01)00278-4 |
0.273 |
|
| 1987 |
Patterson M, Schwartz C, Bell M, Sauer S, Hofker M, Trask B, van den Engh G, Davies KE. Physical mapping studies on the human X chromosome in the region Xq27-Xqter. Genomics. 1: 297-306. PMID 3482420 DOI: 10.1016/0888-7543(87)90028-0 |
0.272 |
|
| 2011 |
Chancellor DR, Davies KE, De Moor O, Dorgan CR, Johnson PD, Lambert AG, Lawrence D, Lecci C, Maillol C, Middleton PJ, Nugent G, Poignant SD, Potter AC, Price PD, Pye RJ, et al. Discovery of 2-arylbenzoxazoles as upregulators of utrophin production for the treatment of Duchenne muscular dystrophy. Journal of Medicinal Chemistry. 54: 3241-50. PMID 21456623 DOI: 10.1021/jm200135z |
0.271 |
|
| 1997 |
Ponting CP, Phillips C, Davies KE, Blake DJ. PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 19: 469-79. PMID 9204764 DOI: 10.1002/Bies.950190606 |
0.271 |
|
| 2001 |
Loh NY, Nebenius-Oosthuizen D, Blake DJ, Smith AJ, Davies KE. Role of beta-dystrobrevin in nonmuscle dystrophin-associated protein complex-like complexes in kidney and liver. Molecular and Cellular Biology. 21: 7442-8. PMID 11585924 DOI: 10.1128/MCB.21.21.7442-7448.2001 |
0.27 |
|
| 1991 |
Lafrenière RG, Brown CJ, Powers VE, Carrel L, Davies KE, Barker DF, Willard HF. Physical mapping of 60 DNA markers in the p21.1----q21.3 region of the human X chromosome. Genomics. 11: 352-63. PMID 1685139 DOI: 10.1016/0888-7543(91)90143-3 |
0.27 |
|
| 1993 |
Flynn GA, Hirst MC, Knight SJ, Macpherson JN, Barber JC, Flannery AV, Davies KE, Buckle VJ. Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation. Journal of Medical Genetics. 30: 97-100. PMID 8445629 DOI: 10.1136/Jmg.30.2.97 |
0.268 |
|
| 1986 |
Davies KE, Ball SP, Dorkins HR, Forrest SM, Kenwrick SJ, King AW, Lavenir IJD, McGlade SA, Patterson MN, Smith TJ, Wilson L, Paulsen K, Speer A, Coutelle C. Molecular analysis of human X-linked diseases. Cold Spring Harbor Symposia On Quantitative Biology. 51: 337-343. PMID 3472730 DOI: 10.1101/Sqb.1986.051.01.039 |
0.268 |
|
| 1986 |
Reeders ST, Breuning MH, Corney G, Jeremiah SJ, Khan PM, Davies KE, Hopkinson DA, Pearson PL, Weatherall DJ. Two Genetic Markers Closely Linked to Adult Polycystic Kidney Disease on Chromosome 16 The Journal of Urology. 136: 987-987. DOI: 10.1016/S0022-5347(17)45182-2 |
0.268 |
|
| 1989 |
Rosenthal A, Speer A, Billwitz H, Cross GS, Forrest SM, Davies KE. Two human cDNA molecules coding for the Duchenne muscular dystrophy (DMD) locus are highly homologous. Nucleic Acids Research. 17: 5391. PMID 2668885 DOI: 10.1093/NAR/17.13.5391 |
0.267 |
|
| 2006 |
Wilding JR, Lygate CA, Davies KE, Neubauer S, Clarke K. MLP accumulation and remodelling in the infarcted rat heart. European Journal of Heart Failure. 8: 343-6. PMID 16330255 DOI: 10.1016/j.ejheart.2005.10.006 |
0.267 |
|
| 1984 |
Rappold GA, Cremer T, Hager HD, Davies KE, Müller CR, Yang T. Sex chromosome positions in human interphase nuclei as studied by in situ hybridization with chromosome specific DNA probes Human Genetics. 67: 317-325. PMID 6336321 DOI: 10.1007/BF00291361 |
0.267 |
|
| 2008 |
Anvret M, Gillberg C, Wahlström J, Albertsson-Wikland K, Davies K. Infantile autism, fragile (X) (q27.3) and RFLP analysis in an extended Swedish family. Clinical Genetics. 34: 265-271. PMID 2906823 DOI: 10.1111/J.1399-0004.1988.Tb02874.X |
0.266 |
|
| 1991 |
Davies K, Mandel J, Monaco A, Nussbaum R, Willard H, Francis M, Ishikawa-Brush Y, Reed V. Report of the committee on the genetic constitution of the X chromosome Cytogenetic and Genome Research. 58: 853-966. DOI: 10.1159/000133183 |
0.265 |
|
| 1985 |
Davies K, Ball S, Dorkins H, Forrest S, Kenwrick S, Lavenir I, McGlade S, Smith T, Wilson L. Molecular genetics of the X-linked muscular dystrophies Pediatric Research. 19: 1071-1071. DOI: 10.1203/00006450-198510000-00026 |
0.265 |
|
| 2005 |
Davies KE. Regulation of utrophin in transgenic mice. Neuromuscular Disorders : Nmd. 15: 648; author reply 64. PMID 16081285 DOI: 10.1016/j.nmd.2005.06.013 |
0.264 |
|
| 2007 |
Davies KE, Khurana TS. A new way to regulate the NMJ. Nature Medicine. 13: 538-9. PMID 17479096 DOI: 10.1038/nm0507-538 |
0.263 |
|
| 2011 |
Goyenvalle A, Babbs A, Wright J, Garcia L, Davies K. P06 AAV-U7snRNA mediated multi exon-skipping for Duchenne muscular dystrophy Neuromuscular Disorders. 21: S8. DOI: 10.1016/S0960-8966(11)70025-6 |
0.262 |
|
| 2006 |
Davies KE, Grounds MD. Treating muscular dystrophy with stem cells? Cell. 127: 1304-6. PMID 17190595 DOI: 10.1016/j.cell.2006.12.010 |
0.261 |
|
| 2007 |
Nowak K, Ravenscroft G, Jackaman C, Lim E, Squire S, Potter A, Fisher R, Morling P, Griffiths L, Papadimitriou J, Sewry C, Fabian V, Lessard J, Crawford K, Bakker A, ... Davies K, et al. T.O.3 Transgenic expression of cardiac actin rescues skeletal actin-null mice Neuromuscular Disorders. 17: 899. DOI: 10.1016/J.Nmd.2007.06.458 |
0.261 |
|
| 2005 |
Watt SM, Hale S, Baban D, Roubelakis M, Moukayed M, Lim J, Ryan DJ, Davies K, Harris AL, Martin-Rendon E. The Centromeric Protein, CEN(P)-F, a Marker of Cell Proliferation Is Regulated by Hypoxia in Human Mesenchymal Stem Cells and Their Bone Marrow Stromal Progeny. Blood. 106: 1385-1385. DOI: 10.1182/blood.v106.11.1385.1385 |
0.26 |
|
| 2015 |
Tan SC, Gomes RS, Yeoh KK, Perbellini F, Malandraki-Miller S, Ambrose L, Heather LC, Faggian G, Schofield CJ, Davies KE, Clarke K, Carr CA. Preconditioning of cardiosphere-derived cells with hypoxia or prolyl-4-hydroxylase inhibitors increases stemness and decreases reliance on oxidative metabolism. Cell Transplantation. PMID 25751158 DOI: 10.3727/096368915X687697 |
0.26 |
|
| 1994 |
Davies KE. Genetic variation and human disease. Principles and evolutionary approaches Trends in Biotechnology. 12: 106. DOI: 10.1016/0167-7799(94)90116-3 |
0.26 |
|
| 1993 |
Morrison KE, Daniels RJ, Campbell L, McPherson J, Davies KE. Dinucleotide repeat polymorphism proximal to the spinal muscular atrophy region at D5S681. Human Molecular Genetics. 2: 1753. PMID 8268953 DOI: 10.1093/hmg/2.10.1753 |
0.26 |
|
| 1995 |
Davies KE, Tinsley JM, Blake DJ. Molecular analysis of Duchenne muscular dystrophy: past, present, and future. Annals of the New York Academy of Sciences. 758: 287-96. PMID 7625698 DOI: 10.1111/j.1749-6632.1995.tb24834.x |
0.259 |
|
| 1989 |
Davies K. Textbook of human genetics (3rd edn): by Max Levitan, Oxford University Press, 1988. £30.00 (viii + 475 pages) ISBN 0 19 504935 7 Trends in Genetics. 5: 317-318. DOI: 10.1016/0168-9525(89)90117-0 |
0.256 |
|
| 1994 |
Blair HJ, Hirst MC, MacKinnon R, Davies KE, Boyd Y. Evaluation of human microdissection clones from the FRAXA region as tools for comparative mapping in the mouse: isolation of a conserved genomic clone close to FMR1. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 5: 584-7. PMID 8000145 DOI: 10.1007/BF00354936 |
0.256 |
|
| 1995 |
Davies KE, Willard HF. Genetics of disease Current Opinion in Genetics & Development. 5: 295-297. DOI: 10.1016/0959-437X(95)80041-7 |
0.256 |
|
| 2009 |
Goyenvalle A, Babbs A, van Ommen GB, Garcia L, Davies KE. Enhanced Exon-skipping Induced by U7 snRNA Carrying a Splicing Silencer Sequence: Promising Tool for DMD Therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1234-1240. PMID 28178473 DOI: 10.1038/mt.2009.113 |
0.256 |
|
| 1991 |
Passos-Bueno MR, Byth B, Love D, Terwilliger J, Ott J, Rapaport D, Vainzof M, Zatz M, Davies KE. Exclusion of the gene responsible for facioscapulohumeral muscular dystrophy (FSH) at 6q23-q27. Journal of the Neurological Sciences. 102: 206-8. PMID 1883411 DOI: 10.1016/0022-510X(91)90070-N |
0.255 |
|
| 1996 |
Morrison KE, Qureshi SJ, Anderson S, Borrett JP, Theodosiou A, Rodrigues N, Blake D, Nesbit A, Davies KE, Porteous DJ, Brookes AJ. Novel transcribed sequences represented in the complex genomic region 5q13. Biochimica Et Biophysica Acta. 1308: 97-102. PMID 8764824 DOI: 10.1016/0167-4781(96)00097-8 |
0.254 |
|
| 1991 |
Ledbetter SA, Schwartz CE, Davies KE, Ledbetter DH. New somatic cell hybrids for physical mapping in distal Xq and the fragile X region American Journal of Medical Genetics. 38: 418-420. PMID 2018083 DOI: 10.1002/Ajmg.1320380254 |
0.254 |
|
| 1985 |
Davies KE. Molecular Biology and Human Disease: edited by Alexander Macleod and Karol Sikora, Blackwell Scientific Publications, 1984. £10.80 (softback) (xi + 271 pages) ISBN 0 632 01167 X Trends in Neurosciences. 8: 547-548. DOI: 10.1016/0166-2236(85)90195-X |
0.254 |
|
| 1989 |
Clarke A, Davies KE, Gardner-Medwin D, Burn J, Hudgson P. Xp21 DNA PROBE IN DIAGNOSIS OF MUSCULAR DYSTROPHY AND SPINAL MUSCULAR ATROPHY The Lancet. 333: 443. PMID 2563824 DOI: 10.1016/S0140-6736(89)90044-5 |
0.253 |
|
| 1991 |
Glass IA, Pirrit LA, White EM, Bell MV, Davies KE, Cockburn F, Connor JM. Linkage analysis in the fragile X syndrome using multiple distal Xq polymorphic DNA markers. American Journal of Medical Genetics. 38: 298-304. PMID 1673301 DOI: 10.1002/AJMG.1320380227 |
0.253 |
|
| 1994 |
Brookes AJ, Siorach EM, Morrison KE, Qureshl SJ, Blake D, Davies K, Porteous DJ. Cloning the shared components of complex DNA resources Human Molecular Genetics. 3: 2011-2017. PMID 7874119 DOI: 10.1093/hmg/3.11.2011 |
0.253 |
|
| 2008 |
Zhang W, ten Hove M, Schneider JE, Stuckey DJ, Sebag-Montefiore L, Bia BL, Radda GK, Davies KE, Neubauer S, Clarke K. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. Journal of Molecular and Cellular Cardiology. 45: 754-60. PMID 18929569 DOI: 10.1016/J.Yjmcc.2008.09.125 |
0.253 |
|
| 2005 |
Hirst RC, McCullagh KJ, Davies KE. Utrophin upregulation in Duchenne muscular dystrophy. Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology / Edited by the Gaetano Conte Academy For the Study of Striated Muscle Diseases. 24: 209-16. PMID 16629055 |
0.252 |
|
| 1999 |
Zerres K, Davies KE. 59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17-19 April 1998, Soestduinen, The Netherlands. Neuromuscular Disorders : Nmd. 9: 272-8. PMID 10399757 DOI: 10.1016/S0960-8966(99)00016-4 |
0.252 |
|
| 1989 |
Speer A, Rosenthal A, Billwitz H, Hanke R, Forrest S, Love D, Davies K, Love D. DNA amplification of a further eion of Duchenne mnscular dystrophy locus increase possibilities for deletion screening Nucleic Acids Research. 17: 6774-6774. DOI: 10.1093/nar/17.16.6774-a |
0.251 |
|
| 1995 |
Pasquini F, Guerin C, Blake DJ, Davies K, Karpati G, Holland P. The effect of glucocorticoids on the accumulation of utrophin by cultured normal and dystrophic human skeletal muscle satellite cells Neuromuscular Disorders. 5: 105-114. PMID 7767089 DOI: 10.1016/0960-8966(94)00042-8 |
0.251 |
|
| 1989 |
Davies KE. Molecular Genetics of Neurological and Neuromuscular Disease: Edited by S. DiDonato, S. DiMauro, A. Mamoli and L. P. Rowland. ISBN 0 8816 7334 X. Price: $162.50. Raven Press, New York, 1988 Neurochemistry International. 14: 101-102. DOI: 10.1016/0197-0186(89)90017-X |
0.251 |
|
| 1991 |
Byth BC, Love DR, Passos-Bueno MR, Davies KE. A new DNA marker, D6S129, identifies a HindIII polymorphism on chromosome 6q. Nucleic Acids Research. 19: 4310. PMID 1678512 DOI: 10.1093/nar/19.15.4310-a |
0.25 |
|
| 1983 |
Davies KE. Genetic Recombination. Understanding the Mechanisms Journal of Medical Genetics. 20: 317-318. DOI: 10.1136/Jmg.20.4.317-B |
0.25 |
|
| 2015 |
Guiraud S, Chen H, Squire S, Edwards B, Burns D, Shah N, Davies S, Wynne G, Russell A, Elsey D, Wilson F, Tinsley J, Davies K. Utrophin modulators significantly improve muscular dystrophy in the mdx diaphragm Neuromuscular Disorders. 25: S260. DOI: 10.1016/J.Nmd.2015.06.271 |
0.249 |
|
| 2016 |
Burns D, Guiraud S, Carr C, Squire S, Edwards B, Chen H, Kennedy T, Babbs A, Shah N, Berg A, Wynne G, Russell A, Elsey D, Harriman S, Wilson F, ... ... Davies K, et al. Utrophin modulation for the treatment of cardiomyopathy in mdx mice Neuromuscular Disorders. 26: S131. DOI: 10.1016/J.Nmd.2016.06.166 |
0.248 |
|
| 2000 |
Danos O, Davies K, Lehn P, Mulligan R. The Journal of Gene Medicine now published in association with two major learned societies The Journal of Gene Medicine. 2: 307-307. DOI: 10.1002/1521-2254(200009/10)2:5<307::Aid-Jgm138>3.0.Co;2-M |
0.248 |
|
| 2007 |
Hodges A, Sharrocks K, Edelmann M, Baban D, Moris A, Schwartz O, Drakesmith H, Davies K, Kessler B, McMichael A, Simmons A. Activation of the lectin DC-SIGN induces an immature dendritic cell phenotype triggering Rho-GTPase activity required for HIV-1 replication. Nature Immunology. 8: 569-77. PMID 17496896 DOI: 10.1038/Ni1470 |
0.248 |
|
| 1981 |
Crampton JM, Davies KE, Knapp TF. The occurrence of families of repetitive sequences in a library of cloned cDNA from human lymphocytes Nucleic Acids Research. 9: 3821-3834. PMID 6169012 DOI: 10.1093/nar/9.15.3821 |
0.248 |
|
| 1996 |
Muda M, Theodosiou A, Rodrigues N, Boschert U, Camps M, Gillieron C, Davies K, Ashworth A, Arkinstall S. The Dual Specificity Phosphatases M3/6 and MKP-3 Are Highly Selective for Inactivation of Distinct Mitogen-activated Protein Kinases Journal of Biological Chemistry. 271: 27205-27208. PMID 8910287 DOI: 10.1074/Jbc.271.44.27205 |
0.248 |
|
| 2019 |
Chatzopoulou M, Claridge TDW, Davies KE, Davies SG, Elsey D, Emer E, Fletcher AM, Harriman S, Robinson N, Rowley J, Russell AJ, Tinsley J, Weaver R, Wilkinson I, Willis N, et al. Isolation, structural identification, synthesis, and pharmacological profiling of 1,2-trans-dihydro-1,2-diol metabolites of the utrophin modulator ezutromid. Journal of Medicinal Chemistry. PMID 31599580 DOI: 10.1021/Acs.Jmedchem.9B01547 |
0.245 |
|
| 2020 |
Tambuyzer E, Vandendriessche B, Austin CP, Brooks PJ, Larsson K, Needleman KIM, Valentine J, Davies K, Groft SC, Preti R, Oprea TI, Prunotto M. Publisher Correction: Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews. Drug Discovery. PMID 31913355 DOI: 10.1038/s41573-019-0059-7 |
0.245 |
|
| 2012 |
Perkins KJ, Davies KE. Recent advances in Duchenne muscular dystrophy. Degenerative Neurological and Neuromuscular Disease. 2: 141-164. PMID 30890885 DOI: 10.2147/DNND.S26637 |
0.244 |
|
| 1991 |
Hirst MC, Nakahori Y, Knight SJ, Schwartz C, Thibodeau SN, Roche A, Flint TJ, Connor JM, Fryns JP, Davies KE. Genotype prediction in the fragile X syndrome. Journal of Medical Genetics. 28: 824-9. PMID 1757957 DOI: 10.1136/Jmg.28.12.824 |
0.242 |
|
| 1998 |
Muda M, Theodosiou A, Gillieron C, Smith A, Chabert C, Camps M, Boschert U, Rodrigues N, Davies K, Ashworth A, Arkinstall S. The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity. The Journal of Biological Chemistry. 273: 9323-9. PMID 9535927 DOI: 10.1074/Jbc.273.15.9323 |
0.242 |
|
| 2008 |
Davies KE, Boris AW. A new editor to mark another era in genetics. Human Molecular Genetics. 17: R99. PMID 18852209 DOI: 10.1093/hmg/ddn299 |
0.241 |
|
| 2016 |
Davies KE. 2015 William Allan Award. American Journal of Human Genetics. 98: 419-26. PMID 26942278 DOI: 10.1016/j.ajhg.2016.01.007 |
0.241 |
|
| 2017 |
Wynne G, Vuorinen A, Emer E, Conole D, Chatzopoulou M, Davies S, Russell A, Guiraud S, Squire S, Berg A, Edwards B, Hemming S, Kennedy T, Moir L, Davies K, et al. Discovery of small molecule utrophin modulators for the therapy of Duchenne muscular dystrophy Neuromuscular Disorders. 27. DOI: 10.1016/J.Nmd.2017.06.348 |
0.24 |
|
| 1991 |
Davies KE, Craig IW. Report of the second X Chromosome Workshop Oxford, UK, January 6-7, 1991 Genomics. 10: 842-846. DOI: 10.1016/0888-7543(91)90473-R |
0.239 |
|
| 1993 |
Willard HF, Davies KE. Mammalian genetics Editorial overview: a sampler of current opinion Current Opinion in Genetics & Development. 3: 387-389. DOI: 10.1016/0959-437X(93)90109-3 |
0.238 |
|
| 2015 |
Guiraud S, Squire S, Edwards B, Chen H, Burns D, Shah N, Babbs A, Davies S, Wynne G, Russell A, Elsey D, Wilson F, Tinsley J, Davies K. Second generation utrophin modulator for the therapy of Duchenne muscular dystrophy Neuromuscular Disorders. 25. DOI: 10.1016/J.Nmd.2015.06.270 |
0.237 |
|
| 1991 |
Tommerup N, Søndergaard F, Hanauer A, Oberle I, Bang J, Barbi B, Bech B, Davies K, Froster-Iskenius U, Gustavson K-, Hagen CBvd, Heiberg A, Kristoffersen U, Mikkelsen M, Miny P, et al. Early prenatal diagnosis of the fragile site AT Xq27.3 associated with Martin‐Bell syndrome Prenatal Diagnosis. 11: 609-619. PMID 1685019 DOI: 10.1002/Pd.1970110818 |
0.234 |
|
| 1992 |
Davies KE. Human genetics. The costs of instability. Nature. 356: 15. PMID 1538769 DOI: 10.1038/356015a0 |
0.234 |
|
| 1988 |
Patterson M, Bell M, Schwartz C, Davies K. Pulsed-field gel mapping studies in the vicinity of the fragile site at Xq27.3. American Journal of Medical Genetics. 30: 581-591. PMID 3177471 DOI: 10.1002/Ajmg.1320300159 |
0.234 |
|
| 2023 |
Roberts TC, Wood MJA, Davies KE. Therapeutic approaches for Duchenne muscular dystrophy. Nature Reviews. Drug Discovery. PMID 37652974 DOI: 10.1038/s41573-023-00775-6 |
0.233 |
|
| 1994 |
Theodosiou AM, Morrison KE, Nesbit AM, Daniels RJ, Campbell L, Francis MJ, Christodoulou Z, Davies KE. Complex repetitive arrangements of gene sequence in the candidate region of the spinal muscular atrophy gene in 5q13. American Journal of Human Genetics. 55: 1209-17. PMID 7977382 |
0.232 |
|
| 1989 |
Bell MV, Patterson MN, Dorkins HR, Davies KE. Physical mapping of DXS134 close to the DXS52 locus Human Genetics. 82: 27-30. PMID 2565864 DOI: 10.1007/BF00288266 |
0.231 |
|
| 2023 |
Guiraud S, Davies K. Utrophin correlates with disease severity in Duchenne muscular dystrophy. Med (New York, N.Y.). 4: 220-222. PMID 37060897 DOI: 10.1016/j.medj.2023.03.005 |
0.23 |
|
| 1988 |
Thibodeau SN, Dorkins HR, Faulk KR, Berry R, Smith AC, Hagerman R, King A, Davies KE. Linkage analysis using multiple DNA polymorphic markers in normal families and in families with fragile X syndrome. Human Genetics. 79: 219-27. PMID 3402993 DOI: 10.1007/BF00366240 |
0.229 |
|
| 1997 |
Davies KE, Clarke AJ, Harper PS. The genetic revolution and medicine in the 21st century European Review. 5: 39-54. DOI: 10.1002/(Sici)1234-981X(199701)5:1<39::Aid-Euro150>3.0.Co;2-6 |
0.229 |
|
| 1983 |
Wieacker P, Davies K, Pearson P, Ropers H. Carrier detection in Duchenne muscular dystrophy by use of cloned DNA sequences. The Lancet. 321: 1325-1326. PMID 6134107 DOI: 10.1016/S0140-6736(83)92429-7 |
0.228 |
|
| 1993 |
Thiselton DL, Kamakari S, Curtis AR, Coleman MP, Davies KE, Lindsay S, Bhattacharya S. Dinucleotide repeat polymorphism at the DXS556 locus. Human Molecular Genetics. 2: 613. PMID 8518809 DOI: 10.1093/Hmg/2.5.613 |
0.226 |
|
| 2015 |
Tinsley J, Muntoni F, Spinty S, Roper H, Hughes I, Ricotti R, Tejura B, Layton G, Davies K. Utrophin modulators to treat Duchenne muscular dystrophy (DMD): Results from a Phase 1b Clinical Trial of SMT C1100 Neuromuscular Disorders. 25. DOI: 10.1016/J.Nmd.2015.06.274 |
0.224 |
|
| 2016 |
Ricotti V, Spinty S, Roper H, Hughes I, Tejura B, Robinson N, Layton G, Davies K, Muntoni F, Tinsley J. Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy. Plos One. 11: e0152840. PMID 27055247 DOI: 10.1371/journal.pone.0152840 |
0.223 |
|
| 2019 |
Muntoni F, Tejura B, Spinty S, Roper H, Hughes I, Layton G, Davies KE, Harriman S, Tinsley J. A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced Diet. Clinical Pharmacology in Drug Development. PMID 30650257 DOI: 10.1002/cpdd.642 |
0.223 |
|
| 1987 |
Davies KE. Duchenne muscular dystrophy: by Alan E. H. Emery, Oxford University Press (Oxford Monographs in Medical Genetics No. 15), 1987. £35.00 (xv + 315 pages) ISBN 0 19 261556 4 Trends in Genetics. 3: 231-232. DOI: 10.1016/0168-9525(87)90244-7 |
0.222 |
|
| 1995 |
Winder SJ, Hemmings L, Bolton SJ, Maciver SK, Tinsley JM, Davies KE, Critchley DR, Kendrick-Jones J. Calmodulin regulation of utrophin actin binding. Biochemical Society Transactions. 23: 397S. PMID 8566285 DOI: 10.1042/Bst023397S |
0.219 |
|
| 1990 |
Temple IK, Baraitser M, Pembrey ME, Butler L, Jacobs P, Davies KE. Unusual presentation of fragile X syndrome The Lancet. 336: 1131. PMID 1978006 DOI: 10.1016/0140-6736(90)92608-K |
0.217 |
|
| Hide low-probability matches. |